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INTRODUCTION 
Systemic Lupus Erythematosus is a connective tissue, auto immune 
disease of which cause is unknown. It causes tissue damage and immune 
system dysfunction by antibodies, T lymphocytes and immune complexes. In 
general the incidence is 2.4 per 100000.It is reported as 9.2 per 100,000 in 
black woman and 3.5 per 100,000 in white woman. It is highly reported in 
Asians. It is more common in the age group of 15 and 64 years. Prevalence is 
more in females. The female to male ratio is 10 to 15:1. 
In Systemic Lupus Erythematosus one or many systems are involved. 
Clinical features are fever, arthralgia, malar or discoid rash, arthritis, fatigue, 
weight loss, oral ulcer, photosensitivity, pericarditis, pleuritis, anemia, 
leucopenia, neuropsychiatric disorder and, renal dysfunction. 
Neuropsychiatric features of Systemic Lupus Erythematosus includes 
central and peripheral nervous system dysfunction and psychiatric 
manifestations. There are 19 neuro psychiatric symptoms, defined by  The 
American College of Rheumatology Ad Hoc Committee1 on Neuropsychiatric 
Lupus Erythematosus Nomenclature 
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Neuropsychiatric Lupus Syndromes   (ACR Nomenclature for NPSLE) 
Central Nervous System 
1.Cognitive dysfunction 
2.Psycosis 
3.Mood disorder 
4.Anxiety disorder 
5.Acute confusional state (delirium) 
6.Seizure 
7.Cerebrovascular disease 
8.septic meningitis 
9.Headache 
10.Myelopathy 
11.Movement disorder (chorea) 
12.Demyelinating Syndrome 
Peripheral Nervous System 
1.Polyneuropathy 
2.Plexopathy 
3.Cranial neuropathy 
4.Myasthenia gravis 
5.Mononeuropathy 
6.Gullian-Barre syndrome 
7.Autonomic disorder 
 
 
 
 
 
Neuropsychiatric disorders in systemic lupus Erythematosus may be 
caused by disease itself or its treatment or due to other factors. The 
etiopathogenesis is multifactorial which includes inflammatory changes 
(caused by cytokine production, anti ribosomal, antineuronal  antibodies and 
phospholipid associated proteins ) and vascular injury of cranial vessels. There 
is no single test to diagnose Neuropsychiatric Lupus, multiple investigations 
are being carried out to identify and assess the disease severity 
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Systemic Lupus Erythematosus(SLE) and PSYCHIATRIC DISORDERS 
Psychiatric manifestations in Systemic Lupus Erythematosus are being 
classified as psychosis, mood disorder (depression and bipolar),anxiety 
disorder, acute confusional state (delirium) and cognitive dysfunction. 
Prevalence is not the same in various studies. Many studies have reported 
different prevalence rates. In general, it comes in the range of 17-75%. 
Different methodology by different professionals and difficulty in 
applying diagnostic criteria explained this different distribution. It is found that 
not only disease and its treatment, psycho social stressors play an important 
role in the development of psychiatric manifestations. Indian studies have 
shown similar pattern of systemic lupus Erythematosus when compared to 
other countries. But the prevalence of psychosis and other psychiatric disorders 
in systemic lupus Erythematosus has been studied a little. This created the 
interest to study the prevalence of psychiatric disorders in patients with 
systemic lupus Erythematosus. 
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REVIEW OF LITERATURE 
Systemic Lupus Erythematosus (SLE) is a connective tissue multi 
system disease in which tissues and cells are damaged by deposition of 
pathogenic antibodies and immune complexes. Clinical features are variable 
from mild joint and skin involvement to severe life threatening internal organ 
disease. American College Of Rheumatology (ACR)2,3  in 1971 ,revised in 
1982 and  in 1997 proposed criteria for diagnosing systemic lupus 
erythematosus (SLE). 
It consists of 11 criterion which includes both clinical and laboratory 
findings. They are 1.Malar rash 2.Discoid Rash 3.Photosensitivity 4.Oral ulcers 
5.Arthritis 6.Serositis 7.Renal Disorder 8.Neurologic disorder 9.Hematologic 
disorder 10.Immunological disorder 11.Positive antinuclear antibody. A Person 
must fulfill 4 of 11 criteria to be classified as Systemic Lupus Erythematosus. 
Neurological involvement is known as Neuropsychiatric systemic lupus 
Erythematosus (NPSLE) in which psychiatric manifestations (psychosis, mood 
disorders, anxiety disorders and acute confusional state, and cognitive 
dysfunction) are being included. 
PATHOGENESIS OF NEUROPSYCHIATRIC SLE (SYSTEMIC LUPUS 
ERYTHEMATOSUS)  
Though mechanism of Neuro Psychiatric  Systemic Lupus 
Erythematosus (NPSLE) is not clearly known, there are two mechanisms 
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explain the pathological process of Neuro Psychiatric  Systemic Lupus 
Erythematosus  (i.e.Vascular and inflammatory).Vascular injury results in 
small and large vessel damage,through hyalinization,perivascular inflammation 
and endothelial proliferation. Inflammatory injury and damage may be caused 
by antinuclear antibodies increased permeability of the blood -brain barrier, 
intrathecal production of inflammatory cytokines. 
Considering autoimmune nature of Systemic Lupus Erythematosus 
(SLE), various autoantibodies are involved in the causation of neuropsychiatric 
manifestations 
SYSTEMIC LUPUS ERYTHEMATOSUS: AUTOIMMUNITY AND 
PSYCHIATRIC DISORDER 
In patients of Neuro Psychiatric Systemic Lupus Erythematosus 
(NPSLE), specific autoantibodies are found in CSF analysis. They are anti 
endothelial antibodies, anti phospholipid, anti neuronal, anti glial 
fibrillarospiny acidic proteins antibodies and anti ribosomal P proteins 
antibodies.Among these, antiendothelial and antiribosomal P protein are related 
to psychiatric manifestations. 
P0, P1 and P2 proteins are located on the larger subunit of the 
eukaryotic ribosomes. A group of auto antibodies are directed against these 
three P proteins. These auto antibodies are present in sera react with epitope of 
twenty amino acid residues, situated at the carboxy terminal end of all P 
proteins. Auto antibodies were identified many years before. 
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Teh and Isenberg4 found that these auto antibodies are identified in 
serum of patients with Neuro Psychiatric Systemic Lupus Erythematosus 
(NPSLE) and correlated with correlated with neuropsychiatric manifestations. 
Anti P antibodies are not found in most of the cases of Systemic Lupus 
Erythematosus (SLE). It is present in the range of 6% to 36%.Bonfa5 et al, 
reported anti P protein antibodies are specific for Lupus Psychosis in his 
Retrospective study done in 1987.Various findings were observed in various 
studies.Some of the studies correlation was not found between anti P antibodies 
and neuropsychiatric manifestations.Specificity is lacking in these studies. 
A review by Zandman Goddar G Et al6 on antibodies and Central 
Nervous System lupus has described twenty brain specific antiobodies which 
are directed against lymphocytotoxic, methy D aspartate receptors, neuronal, 
synaptosomes, glia, and nine systemic antibodies targeted (endothelial cells, 
Nuclear, cytoplasmic, phospholipid,) systemic antigens. 
Toubie et al7 tried to study the correlation of antiphospholipid antibody 
with Neuro psychiatric systemic lupus Erythematosus and found that 96 
patients had Central Nervous System symptoms, more than 50% of these 
patients had Antiphospholipid antibody positivity. Significant difference 
(p<0.001) was present with controls. This study concluded there is positive 
correlation between presence of antiphospholipid antibody and 
neuropsychiatric manifestations. This finding is supported by neuroimaging in 
which abnormal MRI finding in antibody positive patients. 
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Many antibodies were related to psychosis, depression, cognitive 
impairment and other neurological manifestations. No antibody specificity is 
found among neuropsychiatric manifestations. In Systemic Lupus 
Erythematosus patients with depression and psychosis, increased levels of 
anticardiolipin  and antiendothelial antibodies were observed. Antibodies to N-
Methyl D-Aspartate (NMDA) receptor were found to be increased in Systemic 
Lupus Erythematosus patients with depression. All these suggest there is strong 
association between Systemic Lupus Erythematosus and psychiatric disorders. 
Further exploration is needed to study the relationship between psychiatric 
disorders and Systemic Lupus Erythematosus and to find out other factors 
involved in the development of psychiatric disorders (stressful live events, 
disease activity etc) 
PREVALENCE OF PSYCHIATRIC DISORDERS IN SYSTEMIC 
LUPUS ERYTHEMATOSUS (SLE) 
Psychiatric disorders are common in Systemic Lupus Erythematosus. 
According to study by Kaposi8, Mental illness can occur in patients with 
autoimmune disease. 
Buchbinder R and Johnson RT9 showed the prevalence of psychiatric 
symptoms ranges from 17% to 75% As per the study conducted by Hugo10 et al 
in the year of 1996 ,reported  point prevalence of psychiatric disorders was 
18.2%.Majority of the patients diagnosed to have Adjustment 
disorder(11.4%).He applied DSM –III-R to eighty eight(88) patients in his 
study. 
8 
 
Stern and Robbins 11had taken fifty three (53) Systemic Lupus 
Erythematosus patients for study and assessed. Psychosis was present in twenty 
six (26) patients. Based on Presentation of symptoms and treatment response 
patients were categorized to have steroid induced psychosis, psychotic 
depression, organic brain syndrome, unclassified psychosis, schizophrenia. 
In 1967, Guze12 has done study in one hundred and one (101) Systemic 
Lupus Erythematosus patients and found that 12% of patients needed 
psychiatric treatment; 8% of patients were treated in psychiatric hospital. 
patients were found to have schizophreniform disorder, organic brain 
syndrome, affective illness. 
Dubois and Tuffanelli13 in 1964, studied five hundred and twenty (520) 
Systemic Lupus Erythematosus (SLE) patients and found an organically related 
psychosis in 12% of patients. 
A study by O’Conner14 on fourty(40) Systemic Lupus Erythematosus 
patients rated only fourteen(14) as psychologically healthy;  Twenty one (21) 
patients experienced psychotic episodes, which were categorized as either acute 
brain syndrome or functional psychosis (schizophrenia or psychotic 
depression).The remaining  five (5)patients were considered neurotic with 
diagnosis of depression, anxiety or dissociative reaction. 
Rubio Valadolid G et al15 has done cross sectional study in forty six (46) 
spanish patients with systemic lupus erythematosus who attended 
Rheumatology Departments at a university Hospital and found the prevalence 
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of psychiatric disorders in this population. Assessment tools used were DSM-
III-R, the Nottinghan Health profile, symptom check –list 90-Revised,the 
psychological adjustment to illness scale, the integrated program of 
neurological assessment test-Barcelona. The prevalence of psychiatric 
disorders at interview was 33%.The most common diagnoses were affective 
disorders and psycho-organic syndrome. 
In the study conducted by Sabbani et al16, they reported anxiety or mood 
disorders in 32% of patients without Neuro Psychiatric Systemic Lupus 
Erythematosus. The same frequency of psychiatric symptoms (29%) have been 
seen in many patients in  whom criteria for Neuro Psychiatric Systemic Lupus 
Erythematosus (NPSLE) has never met. 
Jonson A et al17 tried to find out the outcome of neuropsychiatric 
systemic lupus erythematosus in  Swedish population in his study. He reported 
that the proportion of patients who developed neuropsychiatric  systemic lupus 
erythematosus (NPSLE) was 38%. 
Ganz et al18 in 1972,tried to reduce the bias seen in prior studies by 
including two rarely used features into their study ,that is –use of a comparison 
group of patients with Rheumatoid arthritis & use of a structured interview. 
More number of systemic lupus Erythematosus patients, amounting to the 
proportion of 71% shown one or more positive responses on those standard 
clinical interview items deemed clinically important. 
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This proportion has come down to 57% if only depressive, 
schizophreniform and organic symptoms were considered (psychophysical 
symptoms being excluded).The group of patients with Rheumatoid arthritis had 
psychiatric disorders amounting to 69%. No differences being made out 
between systemic lupus erythematosus and Rheumatoid arthritis patients with 
respect to psychiatric symptoms has shown. This supported that the psychiatric 
symotoms in patients of Systemic Lupus Erythematosus do not seem to be 
related to central nervous system involvement. Hence Rheumatoid arthritis 
patients also presented with psychiatric disorders. 
In the year of 1981,retrospective analysis by Hall et al19 ,shown that out  
of 56 patients, 25(44%) patients  with systemic lupus erythematosus (SLE) 
were found to have psychiatric symptoms at disease onset or before the 
diagnosis is made. 
Lindal E et al20 has studied Systemic Lupus Erythematosus (SLE) 
diseased population in Iceland. The study was aimed to find out the prevalence 
of psychiatric disorders in patients with Systemic Lupus Erythematosus.81% of 
population are involved in study. It was found that 49% of the Systemic Lupus 
Erythematosus patients diagnosed to have psychiatric disorders as life time 
prevalence. 
Among psychiatric disorders, Depression is more common in patients  
with systemic lupus Erythematosus according to studies of  Brey RL21 ,Mo k 
CC22 and Ainidia23. They have reported the prevalence rate of 16 to 51%. 
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Mood disorders may represent neuropsychiatric manifestations of Systemic 
Lupus Erythematosus disease activity or may be a consequence of the stress of 
having a chronic major disease. 
A prospective study done by K.N.Purandare et al24, has shown 50% 
prevalence of psychiatric illness in patients with Systemic Lupus 
Erythematosus (SLE). Patients were assessed by structured interviews to make 
the diagnosis of psychiatric disorders. Structured proforma was used to collect 
demographic details. Presumptive stressful life event scale has been applied to 
patients. Systemic Lupus Erythematosus disease activity was measured by 
BILAG(British Isles Lupus Assessment Group) index. Patients with psychiatric 
disorders were compared with Systemic Lupus Erythematosus patients without 
psychiatric disorders with respect to age, sex and other demographic variables 
and disease activity, Steroid treatment, stressful life events. This study 
concluded there was no significant difference between patients with psychiatric 
disorders and patients without psychiatric disorders with respect to variables. In 
this study  depressive disorders were common (23.34%) in patients with 
Systemic Lupus Erythematosus. psychotic disorder was not reported in patients 
with Systemic Lupus Erythematosus. 
Lim LC25 et al has done cross cultural case control study to find out 
psychiatric morbidity in patients with systemic lupus erythematosus in an 
oriental population. In this study, thirty (30)  patients with Systemic Lupus 
Erythematosus and twenty nine (29) controls with Rheumatoid Arthritis were 
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enrolled. The patients with Systemic Lupus Erythematosus in Singapore had 
greater psychiatric morbidity than the patients with Rheumatoid Arthritis. 
The frequency and type of psychiatric disease were assessed in forty 
(40) patients suffering from systemic lupus erythematosus (SLE) and 27 
control subjects with Rheumatoid arthritis or inflammatory bowel disease. The 
psychiatric disorders at the time of interview were the same in the two groups, 
but the patients with Systemic Lupus Erythematosus had experienced more 
episodes of psychiatric disorders in the past and psychiatric symptoms occurred 
only in this group. 
In the study conducted by Chin et al26, Seventy nine(79) malyasian 
patients who attended a university systemic lupus erythematosus (SLE) Clinic 
were included as study population. The study period was 6 months. Clinical 
interview schedule for psychiatric disorder based on ICD-9 administered to 
patients. Forty (40) were found to have psychiatric disorder, twenty six (26) 
having depressive neurosis, six(6) anxiety neurosis, five (5)endogenous 
depression and three(3) dementia. When compared to patients without 
psychiatric disorders, family support and self confidence is low in patients with 
psychiatric disorders. There was significant difference (p<0.01) present 
between these two groups. 
METHODOLOGICAL STUDIES 
A review by Ganz et al18 in 1972, found that the studies being done so 
far had  many flaws in methodology. Hence comparison & generalizability of 
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studies became questionable. Subsequent reviews have continued to try and 
assess the reasons for wide ranging variability in findings of studies. 
Twenty-one(21) studies on the prevalence and type of psychiatric 
symptoms in patients with Systemic lupus erythematosus (SLE) were evaluated 
by Wekking27 in 1993.This review concluded that Variability in findings may 
be attributed to different assessment techniques and different methodological 
aspects. Consistent relationship was not found between the psychiatric 
symptoms and other symptoms of Systemic Lupus Erythematosus 
(SLE).However, the relationship between the experience of psychosocial 
stressors and perception of the severity of illness was made out. When patients 
were compared with controls (patients with other chronic diseases), there was 
significant difference noted between two groups with respect to prevalence and 
type of psychiatric symptoms. In Patients with psychosis ,disease symptoms 
may be related to neuropsychiatric involvement of Systemic Lupus 
Erythematosus based on some evidence. 
SYSTEMIC LUPUS ERYTHEMATOSUS AND COGNITIVE 
DYSFUNCTION 
One of the common neuropsychiatric manifestation of Systemic Lupus 
Erythematosus (SLE) is cognitive dysfunction. It was assessed by using various 
neuropsychological tests in the absence of other neurological and psychiatric 
disorders. These tests used to differentiate mild cognitive impairment seen in 
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Systemic Lupus Erythematosus patients in the absence of neuropsychiatric 
involvement. 
In General, approximately 66% of patients with Systemic Lupus 
Erythematosus (SLE) reported to have cognitive deficits. In cognitive tasks, 
processing speed, working memory and information processing are being 
commonly affected. Different studies yield different results in different 
population which has explained complex nature and heterogeneity of Neuro 
Psychiatric Systemic Lupus Erythematosus (NPSLE). 
Forty Six (46) patients with Systemic Lupus Erythematosus in the age 
group of 16-65 years and controls (matched with cases ) were enrolled in a 
cross sectional population based study by Loukkola et al28.They have 
underdone medical and neurological examinations and They were assessed by 
applying neuropsychological testing to diagnose cognitive dysfunction. Based 
on these examinations, study population  was divided into two groups i.e 
patients with neuropsychiatric Systemic Lupus Erythematosus(NPSLE, n=15)  
and patients of non neuropsychiatric Systemic Lupus Erythematosus (non 
NPSLE, n=41).It is found that cognitive impairment is more in patients with 
neuropsychiatric Systemic Lupus Erythematosus (NPSLE) than patients of non 
neuropsychiatric Systemic Lupus Erythematosus (non NPSLE).Among patients 
with patients with cognitive impairment, deficits were noted in the domains of 
memory, psychomotor speed and complex attention. 
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The relationship between a cognitive impairment and symptoms of 
depression, pain, fatigue and perceived cognitive dysfunction was studied by 
Kozora E et al29.Tool which used  to assess the patients was ACR (American 
College of Rheumatology neuropsychology research battery for Systemic 
Lupus Erythematosus (ACR-SLE battery).Population participated in the study 
was seventy eight (78).Neuropsychiatric symptoms were seen in  thirty-one 
(31) patients of Systemic Lupus Erythematosus(NPSLE).Twenty two (22 ) 
patients were classified as non neuropsychiatric Systemic Lupus 
Erythematosus(non-NPSLE) and twenty five(25) persons were as healthy 
controls. Patients with neuropsychiatric Systemic Lupus Erythematosus (both 
NPSLE and non NPSLE) were found to have more fatigue, pain and increased 
levels of cognitive problems and depression. But the correlation between 
cognitive impairment and symptoms of depression and others was found only 
in patients with neuropsychiatric Systemic Lupus Erythematosus (NPSLE). 
SYSTEMIC LUPUS ERYTHEMATOSUS AND PSYCHOSIS 
Psychosis has long been known to be associated with Systemic Lupus 
Erythematosus and Systemic Lupus Erythematosus is considered in the 
differential diagnosis of acute psychosis in the second decade. 
The reported prevalence of psychosis has varied from 2% to 7%.Besides 
being etiologically related to psychosis, patients with Systemic Lupus 
Erythematosus  also encounter the risk of corticosteroid induced psychosis. 
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In the study by Hall et al19 in 1981, 14(25%) of the fifty six (56) were 
classified as psychotic. Ganz et al18 in their review in 1972 found only five( 5) 
patients (7%) with schizophreniform symptoms and two( 2) of these patients 
also had organic symptoms. 
Fernandez Ga de Las Heras V et al30, presented the case report of a 
woman presenting with psychosis, later found to have antiphospholipid 
antibody syndrome secondary to systemic lupus Erythematosus. The clinical 
picture of psychosis was the major manifestation of Systemic Lupus 
Erythematosus  with antiphospholipid antibodies. 
It further explained complex presentation of Systemic Lupus 
Erythematosus and the diagnosis can be made by measuring antiphospholipid 
antibodies. 
Lim L et al31 reported an association was found between neurological 
disease and psychotic symptoms in patients with Systemic Lupus 
Erythematosus. In half of the patients with Systemic Lupus Erythematosus, 
there was evidence of present and past psychiatric disorder. 
Cai YM et al32described a case of Systemic Lupus Erythematosus 
presenting with mixed paranoid and affective organic psychotic state. 
Appenzeller S et al33, tried to evaluate the frequency and risk factors of 
acute psychosis in a large cohort of patients with systemic lupus erythematosus 
and aimed to identify clinical and laboratory variables useful in differentiating 
acute psychosis as a primary manifestation of central nervous system from 
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corticosteroid induced psychosis. In this study, Five hundred and thirty seven 
(537)consecutive patients with Systemic Lupus Erythematosus (SLE) were 
enrolled, and followed up for 4 to 8.8 years. multivariate regression with 
automatic backward stepwise selection was used to find out the frequency and 
risk factors associated with steroid induced psychosis and psychosis due to 
disease perse. Acute psychosis was found in 89 patients of 520 (17.1%)  
Systemic Lupus Erythematosus patients. 
Among eighty nine (89) patients, Psychosis primary to Central Nervous 
System involvement was diagnosed in fifty nine(59) of 89 patients, 
corticosteroid induced psychosis in twenty eight (28) patients and primary 
psychotic disorder  was not related to SLE or medication in two(2) patients. In 
nineteen (19) patients, Psychosis  was due  to Systemic Lupus Erythematosus  
at disease onset  and was associated with disease activity. During follow up of 
Systemic Lupus Erythematosus patients, psychosis was identified in forty (40) 
patients and it was related to antiphospholipid antibody positivity which was 
less frequently seen with cutaneous and renal disorder. 
Disease activity was present in all patients. Hypoalbuminemia was 
reported when psychosis developed in ten (10) of these patients. T.prednisone 
was being taken by all the patients in the dose of 0.75 to 1 mg/kg body weight. 
After tapering steroid, psychosis started to settle in all patients. Systemic Lupus 
Erythematosus (SLE) related psychosis was seen in 11.3% of patients and 
Systemic Lupus Erythematosus (SLE) with neuropsychiatric manifestations 
caused the recurrence of primary psychosis. Though corticosteroids can 
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produce psychiatric symptoms and psychosis, the association was poorly 
established. 
In the Review by Lewis DA et al34, twenty nine (29) studies related to 
steroid efficacy, fourteen cases (14) of steroid induced psychosis and seventy 
nine (79) cases from the literature were being included and reviewed. It was 
found that 5% of steroid treated patients can have psychiatric disturbances, 
Mood symptoms/psychotic symptoms being the commonest seen in many 
patients. It can occur early in the course of therapy. The risk factors for 
development of steroid induced psychiatric syndrome being female sex, high 
dose and Systemic Lupus Erythematosus  itself. 
In a prospective cohort study of Chau S Y et al35, ninety two (92) 
patients with Systemic Lupus Erythematosus ,Corticosteroid induced psychosis 
was observed in 5% of patients. Route of administration and dose of steroid 
were not  good predictors of psychosis occurrence. Various factors have been 
proposed to predict the occurrence of psychosis in patients with Systemic 
Lupus Erythematosus. They are family history of psychiatric illness, past 
history of psychiatric illness, low complement and low albumin and creatinine. 
Hypoalbuminemia was found to have good predictive value after multivariate 
analysis 
Sirosis F36 shifted the focus from short term reactions to cognitive 
deficits resulted from steroid treatment in his review. Incidence of delirium and 
withdrawl symptoms were reported. 
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A case of systemic lupus erythematosus with central nervous system 
involvement (CNS lupus) was reported by Ikenouchi A et al37. The plasma 
levels of homovanillic acid (HVA) and brain –derived neurotrophic factor 
(BDNF), 3-methoxy-4-hydroxyphenylglycol (MHPG) were found to be raised 
in patients with severe CNS lupus. This study suggested measurement of 
plasma HVA, MPHG, BDNF may help to predict the disease severity in 
patients with neuropsychiatric Systemic Lupus Erythematosus and to 
differentiate the psychosis caused by steroid treatment 
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)AND BIPOLAR 
DISORDER 
Systemic Lupus Erythematosus can cause bipolar disorder as 
independent manifestation and it may caused by steroid treatment similar 
steroid induced psychosis. 
One case report by Khan S38has shown that Thirty two(32) years old 
woman presented to hospital who was diagnosed to have mood (First manic 
episode) disorder, was found to have Systemic Lupus Erythematosus (not 
diagnosed previously)based on physical examination and laboratory  
investigations. 
Brey et al21studied neuro psychiatric syndromes in Systemic Lupus 
Erythematosus reported forty percent(40%) of the patient had mood disorder in 
2002.The incidence of mood disorder was fifty seven percent (57%)reported by 
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another study done by sibbit et al39 in the year of 2002.These studies support 
that Systemic Lupus Erythematosus can produce mood disorder. 
Steroid therapy associated psychiatric disturbances was documented in 
fifty five (55) case reports by ling et al40. In majorty of the cases (72%) 
presented with psychotic symptoms and mood symptoms. 
A review by lewis and smith41 by taking seventy nine(79) case reports of 
psychiatric symptoms, found that psychotic symptoms were present in seventy 
one percent(71%).seventy five (75) of the seventy nine(79) cases had mood 
symptoms. 
Steroids withdrawl was more associated with development of 
psychiatric symptoms than steroids administration. It was reported in eight 
cases. All eight cases(8) had mood disturbances; mania was seen in four 
(4)patients. depression was reported in two(2) patients. Two(2) patients 
presented with mixed symptoms. Hallucinations were present in eight (8)cases 
and delusions were present in five(5) cases as psychotic symptoms. 
Wada k et al42 studied mood disorder induced by steroids in nine (9) 
patients. DSM-IV criteria was used to diagnose mood disorder. Clinical 
symptoms of bipolar disorder were seen in nine (9) patients treated with 
corticosteroids. Four patients (4) had manic or hypomanic within a short period 
following steroid pulse therapy. Subacute (1-3months) onset was present in 
seven (7) patients who had hypomanic or manic episode. Psychotic symptoms 
were associated with manic episodes in six(6) patients. In all patients, 65.6 % 
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of the episodes were manic episodes. Psychosocial stressors preceded mood 
episodes in seven patients. 
Psychosocial stressors and corticosteroid treatment were associated with 
recurrence of the mood episodes. Corticosteroid induced mood disorder had 
some typical clinical features that is subacute onset, presence of psychotic 
features and more number of manic episodes. These are the findings concluded 
from the above study. 
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND DEPRESSION 
The most frequently reported psychiatric disorder in patients with 
Systemic Lupus Erythematosus is depression. Prevalence of depression varies 
in the range of 16% to 51%. Neuropsychiatric manifestations of Systemic 
Lupus Erythematosus (SLE) disease activity may be expressed in the form of 
depression or stress of having a chronic major disease may cause depression. 
Relationship with steroids should be considered. The link between disease 
activity and depression is not clear based on available data. 
Stern et al 11 diagnosed mild to moderate depression in eight(8 )patients 
out of twenty nine(29) patients in his study. Psychiatric intervention was 
needed for three(3) of these patients. 
Schizophreniform symptoms were less common than organic symptoms 
and depression. Depression was seven times more common than that of 
symptoms of schizophrenia. This was found in the review, done by Ganz et 
al18.This review found that only depressive symptoms were observed in thirteen 
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(13) patients, schizophreniform symptoms with depressive symptoms were 
seen in eleven (11)patients. Organic symptoms were not present. 
A study was done to assess the prevalence of psychiatric disorders in 
patients with systemic lupus erythematosus and compare with patients of 
Rheumatoid arthritis by Hall et al19. Organic symptoms were similar amounting 
to 22% of cases in both groups. Depressive symptoms were little higher in 
patients with Systemic Lupus Erythematosus (SLE) than patients of 
Rheumatoid Arthritis (RA).It was about 51% for Systemic Lupus 
Erythematosus and 47% for Rheumatoid Arthritis. 
Chin CN26 studied prevalence of psychiatric disorders among 
malyasians  with systemic lupus Erythematosus. In this study more than 50% 
of the patients presented with psychiatric disorders. Most common psychiatric 
diagnosis was depression. No difference was found between patients with 
psychiatric disorders and patients without psychiatric disorders with respect to 
severity of the disease, duration of illness and age. 
Twenty five (25) patients with systemic lupus Erythematosus were 
compared with controls of twenty five(25) patients with Rheumatoid Arthritis 
in Magner MBA study43. The study sample were taken from Groote schur 
hospital outpatient department and assessed. Psychiatric evaluation was done 
by using Mini Mental State Examination and the present state examination. The 
results of this study have shown that Prevalence of neurotic depression was 
high than other psychiatric disorders in both groups. It was little higher in 
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patients of systemic lupus Erythematosus ((40% in systemic lupus 
Erythematosus and 32% in Rheumatoid Arthritis).Organic disorders and 
psychosis were not found in both groups and psychiatric disturbances were not 
related to steroid use. It was suggestive of psychiatric disorders in patients with 
systemic lupus Erythematosus may be contributed by psychosocial factors 
rather than organic factors. 
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)AND ANXIETY 
The relationship  between anxiety disorder and Systemic Lupus 
Erythematosus can be explained by many factors includes skin rash, scarring 
alopecia, Anemia, elevated Cortisotrophin releasing factor (CRF),HPA 
dysregulation, autoimmune thyroid function. There is also close relationship 
between anxiety and depression exists. 
Segui J et al44 did longitudinal study in active and inactive stages of the 
systemic lupus Erythematosus disease. It was found that one patient had mixed 
anxiety and depressive symptoms, five patients had Generalized Anxiety 
Disorder, two patients had panic disorder. 
A study was done in patients  with systemic lupus Erythematosus by 
Lindal E et al20 in Iceland. This study reported that Anxiety disorders were 
found in patients with systemic lupus Erythematosus .Phobia was the 
commonest disorder (56%), next is Generalized Anxiety disorder (12%), 
followed by agoraphobia  with and without panic, simple, social phobia. The 
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prevalence was more when compared to General population. This study 
suggested that social phobia may lead to social withdrawl. 
In the study of Slattery MJ45 et al, patients who attended the national 
institute of arthritis and musculoskeletal and skin diseases outpatient 
department were taken. Fifty (50) adult patients fulfilled the inclusion criteria 
and assessed. This study showed that Obsessive-Compulsive Disorder (OCD) 
was 10 to 15 times more common in this patients of systemic lupus 
Erythematosus. The study results were compared with community –based 
studies of Obsessive and Compulsive Disorder. 
This study helped to explore relationship between Obseesive and 
Compulsive Disorder and systemic lupus Erythematosus and need of further 
studies emphasized. 
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND QUALITY OF 
LIFE, STRESSFUL LIFE EVENTS 
Quality of life in Systemic Lupus Erythematosus has been found in 
various studies. Systemic lupus Erythematosus disease morbidity and outcome 
was being evaluated based on quality of life measures. When compared to 
other medical illnesses, it is found that patients with Systemic Lupus 
Erythematosus to enjoy a poorer quality of life. Some studies proposed the 
hypothesis of higher disease activity or higher psychological stress may be 
associated with lower quality of life. The findings of the results are equivocal. 
Various disease activity measures like SLEDAI (Systemic Lupus 
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Erythematosus (SLE) Disease Activity Index), SLAM (Systemic Lupus 
Activity Measure), SLICC(Systemic Lupus International Collaborating Clinics) 
used to assess the disease severity  with the help of blood tests. Well being and 
function of an individual and social impact of the disease are not being 
measured by these tools. Patients with psychiatric disorders scored high. This 
supported that psychosocial stress cannot be ignored. 
Multiethnic study by Friedman AW46 reported various results. In this 
longitudinal study, disease outcome was observed. Two hundred and twenty 
four patients (224) with initial stage of systemic lupus Erythematosus (SLE) 
were included. Population distribution were eighty three (83) African 
American, seventy (70) Hispanic, seventy one(71)white people. The 
participants were assessed by using physical and mental summary measures of 
36 item and short form 36 Health Survey. The results of this study have shown 
that Hispanic patients had impact on functioning due to helplessness. This was 
less observed in African American and white patients. Helplessness, fatigue, 
pain, illness related behavior related to physical and mental functioning and 
pain was related to only physical health. This study concluded that disease 
activity and damage measures had lesser impact than pain, fatigue and patient’s 
attitude towards disease. 
Health related quality of life in patients with early stage of systemic 
lupus Erythematosus was observed  in another study 47from multiethnic 
LUMINA (Lupus in Minorities: Nature versus nurture).In this study, three 
hundred and forty six (346)patients were participated. The findings have shown 
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that low scores on subscale of the SF-36(Short Form -36), suggestive of quality 
of life was poorer than general population. Poor self reported health related 
quality of life was predicted by many factors including old age, fibromyalgia, 
fatigue and helplessness. It was also predicted by demographic, economic, 
psychological and behavioral factors. 
One hundred and twenty nine(129) patients with systemic lupus 
Erythematosus attending medical centre as out patient were taken and studied 
cross sectionally by Huang HC et al48.The relationship between quality of life, 
health promoting life style and disability was studied  by applying visual 
analogue scale, Pittsburgh sleep quality index and The Hospital Anxiety and 
Depression Scale and short form-36,items being measured are pain, fatigue, 
quality of life, anxiety and depression. The results have shown that 20%-32% 
of patients had anxiety and depression and seventy two (72) patients suffered 
by poor sleep quality. This analysis concluded that there was no significant 
relationship between health promoting lifestyle and physical component of 
health but health promoting life style had impact on mental component of life 
in patients of systemic lupus Erythematosus. Mental component of life was 
facilitated by health promoting life style. 
Fortin PR et al49 studied ninety six (96) patients with systemic lupus 
Erythematosus. They were assessed at baseline and followed up for four (4) 
months. SLICC (Systemic Lupus International Collaborating Clinics) and ACR 
DI(American College of Rheumatology Damage Index) used to measure 
damage caused by lupus. Socio demographic details collected and lupus 
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damage was measured at first time. Subsequent visits lupus activity [SLEDAI 
(Systemic Lupus Erythematosus (SLE) Disease Activity Index)/SLAM-R 
(Systemic Lupus Activity Measure-Revised)], health status[HAQ(Health 
Assessment Questionnaire),SF-36(Short Form)] and immunological assessment 
done. The relationship between General health and physical function and lupus 
activity analysed. Patients with systemic lupus Erythematosus have shown poor 
health status based on results. 
Seventy three (73) patients with systemic lupus Erythematosus (70 
females and 3 males) were examined by Khanna S et al50 in his study. Quality 
of life and disease activity was measured. World Health Organization Quality 
of life-Bref (WHOQOL-Bref) was used to assess the quality of life and 
Mexican Systemic Lupus Erythematosus Disease Activity Index (Mex-
SLEDAI) was applied to measure the disease activity. It was found that no 
significant correlation between disease activity and social and environmental 
domains of Quality of life (QOL).In physical and psychological domains, 
significant correlation was observed between disease activity and quality of 
life. P value (p=0.001[physical],p=0.01 [psychological]) were significant. This 
suggested that patients with lower quality of life had higher disease activity 
scores. There was no correlation between the age, disease duration and quality 
of life found from the results of the study. 
The relationship between Quality of life and disease activity was 
explored in the study conducted by Perez-Cuevas JB et al51. In this study, sixty 
seven ( 67) patients with systemic lupus Erythematosus were selected. All 
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patients  were found to be females. Quality of life was assessed using Medical 
Outcomes Study Short form Scale SF-36 (MOS-SF 36) and Mexico-SLE 
Disease Activity Index (MEX-SLEDAI) was used to measure the disease 
severity. The study  results showed that patients had low value in Quality of 
life suggesting that patients had poor physical role and general function and 
there was no correlation found between age and quality of life. 
Wang C et al52 studied the relationship between quality of life (self 
reported), disease activity, damage, impairment ,disability  and handicap in 
patients with systemic lupus Erythematosus in the year 2001.It was a cross 
sectional study. Various Assessment tools used in this study to measure the 
variables. Based on the results shown from this study, disease activity was 
associated with poor general health and disease damage was correlated with 
poor physical function. Overall this study concluded that many factors like 
disease activity and disease damage, daily activity and mobility ,pain, physical 
role are correlated with health status of patients with systemic lupus 
Erythematosus. 
Few negative studies have been reported in patients with systemic lupus 
Erythematosus in relation to disease activity and quality of life. 
Hanly JG53 studied ninety six (96) patients with systemic lupus 
Erythematosus to explore the relationship between the disease activity and 
quality of life. It was a cross sectional study and standard instruments were 
used to measure the disease severity (SLEDAI- Systemic Lupus Erythematosus  
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Disease Activity Index),damage (SLICC-Systemic Lupus International 
Collaborating Clinics)/ACR DI- American College of Rheumatology Damage 
Index) ,Quality of life [MOS SF-36-Medical Outcomes Study Short form 
Scale-36).Most of the participants were Caucasian (91%) and 96% were 
females. This study showed that there was no correlation between disease 
activity,  damage and quality of life suggesting that quality of life ,disease 
activity and cumulative damage were not significantly related to each other. 
Quality of life was not solely determined by disease activity and damage. 
A study conducted by Jolly M et al54 concluded that there was no 
significant difference between disease activity /damage and quality of life. 
Therefore these were not good indicators of quality of life in patients with 
systemic lupus Erythematosus. 
In systemic lupus Erythematosus patients ,psychosocial process in 
stressful situations, coping skills and social support were assessed by E.kozora 
et al55.Patients were compared with patients having Rhematoid arthritis and 
healthy controls. In this study,fifty two (52) patients with systemic lupus 
Erythematosus (SLE),twenty nine (29) patients with Rheumatoid arthritis and 
twenty seven (27) healthy controls were enrolled. Psychological status, 
stressful life events, coping skills and social support were assessed by multiple 
regression analysis. When compared to patients with Rheumatoid arthritis and 
healthy controls, patients with systemic lupus Erythematosus (SLE) had greater 
psychological distress. Depressive symptoms and distressed mood state were 
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related to use of disengaging and emotional coping skills in patients with 
systemic lupus Erythematosus. 
In another study conducted by Elizabeth Kozora et al29,the relationship 
between life stress, coping and cognition was assessed. In this study, thirty one 
(31) patients with NPSLE (Neuro psychiatric Systemic Lupus Erythematosus) 
and 22 patients without neuropsychiatric manifestations had participated. 
Twenty five (25) healthy controls were taken in this study. The study findings 
showed that patients with systemic lupus Erythematosus (Both with and 
without neuropsychiatric manifestations) had more negative and disengaging 
coping skills and they had more negative life stress events  in the past 6 to 12 
months when compared to controls. Patients with neuropsychiatric systemic 
lupus Erythematosus (SLE)  showed correlation between cognitive impairment 
and negative life stress events and negative coping skills in the past 6 -12 
months.  
Hutchinson GA et56 al tried to find out that psychiatric disorders are due 
to the disease itself or due to the stress of having chronic disease. Forty 
five(45) systemic lupus Erythematosus (SLE) patients compared with two 
control groups. They found that major depression was the most common 
diagnosis among control groups. Psychotic illness was more prevalent in 
systemic lupus Erythematosus  group. It has shown that major depression in 
systemic lupus Erythematosus (SLE) may be due to the stress of having chronic 
disease. Psychotic symptoms may be related to systemic lupus Erythematosus 
disease per se. 
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In the study of Wada K et al42, 9 patients of corticosteroid induced mood 
disorder examined and found that psycho social stressors was associated with 
recurrence of mood episodes. 
In a study of Nery FG et al57,  major depression was associated with life 
events. 
Magner MB43  studied   25 patients with systemic lupus Erythematosus 
and compared with controls of having Rheumatoid Arthritis. It was observed 
that Psychiatric morbidity in SLE was due to psycho social factor rather than 
organic factors. 
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) DISEASE ACTIVITY 
AND PSYCHIATRIC DISORDERS 
In the study conducted by Segui et al45, active and inactive stages of the 
systemic lupus Erythematosus disease was compared. Lower levels of 
psychological distress and low grade anxiety was found in patients with 
inactive stagese of disease. They also scored less in pain perception and they 
have good general function and occupational activity. On comparison of active 
and inactive stages of the disease, no significant differences were  found with 
respect to cognitive impairment, grades of depression and physical diability. 
This study results have shown that during active stage of the disease , systemic 
lupus Erythematosus patients had psychological impairment ,can be associated 
with physiological impact of the disease activity on patients. Patients with 
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systemic lupus Erythematosus reacted in a different way when they faced 
stressful events. 
In a another longitudinal study of active and inactive stages of the 
disease by segui J et al45 , patients with systemic lupus Erythematosus were 
examined for psychiatric disorders and psychosocial dysfunction. The study 
period was 6 months. Twenty (20) patients with systemic lupus Erythematosus 
who had disease flare were consecutively selected. The psychiatric and 
psychosocial assessment was repeated one year later when patients showed the 
symptoms and signs of disease activity. All patients who have been evaluated 
were females. In the acute episode of Systemic Lupus Erythematosus, eight 
(40%) psychiatric cases were diagnosed as per clinical interview schedule. Two 
(10%) cases were  diagnosed to have psychiatric illness one year later when 
patients had not shown disease activity. 
The correlation between psychiatric disorder and disease activity was 
studied in systemic lupus Erythematosus patients by Lim Lc et al31.It was done 
in patients of Singapore. This study revealed that psychopathology was 
contributed by disease related psychological stress. Other etiological factors 
were patients perception of symptoms severity includes myalgia, arthritis). 
There was no correlation between psychiatric and neurological disease 
and clinical or laboratory indices of disease activity according to Lim Lc et al31. 
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According to Brey RL21,Mok CC22 and Ainidia23 studies mood disorders 
may represent neuropsychiatric manifestation of disease activity or may be due 
to stress of having chronic disease. 
KN Purandare24 found that patients with psychiatric disorders were 
similar to patients without psychiatric disorders in relation to  lupus activity. 
Appenzeller Set al25 reported psychosis secondary to systemic lupus 
Erythematosus disease onset related to disease activity in nineteen (19)  of fifty 
nine (59) patients in his study. This supported disease activity was associated 
with psychiatric morbidity. 
Psychiatric morbidity was not associated with disease activity according 
to study Hugo et al10. 
Hypothesis of Presence of and severity of major depression is associated 
with systemic lupus Erythematosus disease activity was studied by Nery FG et 
al57 in patients with systemic lupus Erythematosus(SLE). The study population 
included was seventy one (71) patients.They were assessed for psychosocial 
stressors, presence of major depressive episode, systemic lupus Erythematosus 
(SLE) disease activity/damage and functional disability. Greater severity of 
systemic lupus Erythematosus disease activity was found in patients with major 
depression when compared to Systemic Lupus Erythematosus  patients without 
depressive disorder. It was also observed that patients with depressive disorder 
had significant life events. This study concluded that there was direct 
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correlation present between depression severity and disease activity and 
functional disability. 
In Multiple linear regression analysis, controlling for stressful life events 
and previous major depressive episodes, demonstrated that systemic lupus 
Erythematosus disease activity still was associated with depression severity 
(p=0.014) 
These results support the hypothesis that Systemic Lupus Erythematosus 
(SLE)disease activity is a potential risk factor for the presence and severity of 
major depression in patients with systemic lupus Erythematosus. 
INDIAN STUDIES 
Systemic Lupus Erythematosus (SLE) is less common in India than 
western countries. Reported point prevalence is 3 per 100,000 according to 
study58 conducted in rural population. It appeared to be less when compared to 
prevalence of systemic lupus Erythematosus in western countries. (124/100,000 
in United States of America59,12.5/100,000 in England60 and 39/100000 in 
Finland61. 
More number of systemic lupus Erythematosus cases are reported in 
some of the Indian  hospitals. On going   Prospective study from pune named 
Copcord Bhigwan study reported the incidence rate of 1 per 25,000 person 
years means 4 per 10000 population per year. Many case reports were 
documented in old literature. In many of the literature, neurological and 
medical aspects were explored. 
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In the year of 1978, two (2) cases of systemic lupus Erythematosus 
(SLE)-psychosis were reported and one patient of SLE related delirium was 
reported by Raju DS et al62.  
Dube S et al63 reported a case of psychosis in a patient with Systemic 
Lupus Erythematosus(SLE) in 1981. 
Robert M et al64 tried to study the pattern of neuropsychiatric 
involvement in patients with Systemic Lupus Erythematosus. Fifty patients 
(50) patients who fulfilled the criteria for Systemic Lupus Erythematosus were 
taken over a period of 16 months. All the patients who found to have 
neuropsychiatric manifestations were females. Thirty nine (39) female patients 
out of fifty (50) Systemic Lupus Erythematosus cases had neuropsychiatric 
Systemic Lupus Erythematosus (NPSLE).It was about 78%.Noted mean age 
was 25.66 years (range:11-14 ).Headache was the common presenting 
symptom, seen in twenty (20) cases amounting to 55.6%.Eight(8) patients had 
seizures(20.51%) and six(6) cases were diagnosed to have psychosis (16.2%). 
Chandrasekaran AN et al65 reported neuropsychiatric manifestations in 
32.4% of patients with Systemic Lupus Erythematosus. Psychosis was seen in 
21.7% of patients and depression was reported in 22.6%. of patients. 
Clinical features in male patients of Systemic Lupus Erythematosus was 
studied by Pande et al66.When compared to females, psychosis is less common 
in males with lower prevalence was observed. 
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In Indian patients with Systemic Lupus Erythematosus, prevalence and 
clinical association of the antiribosomal antibodies was studied by Chandran V 
et al67. Two hundred and two (202) patients were examined for presence of 
antibodies. IgG anti-P positivity was seen in 31out of 202 patients amounting 
to (15.35%). 
Psychiatric morbidity was studied methodologically in very few studies. 
A systemic study of psychiatric morbidity in patients with systemic 
lupus Erythematosus was conducted in the year of 1999 by Purandare et 
al24.Structured clinical interview for Diagnosis was used for DSM-III-R. 
Among the study population of thirty (30) patients, psychiatric disorders were 
present in 50% of the patients. Among psychiatric disorders depressive 
disorders being the commonest presentation.36.67% of patients had depressive 
disorders. 
Seventy three (73) patients with Systemic Lupus Erythematosus (70 
females and 3 males) were examined by Khanna S et al50 in his study. Quality 
of life and disease activity was measured. World Health Organization Quality 
of life-Bref (WHOQOL-Bref) was used to assess the quality of life and 
Mexican Systemic Lupus Erythematosus Disease Activity Index (Mex-
SLEDAI) was applied to measure the disease activity. It was found that no 
significant correlation between disease activity and social and environmental 
domains of Quality of life (QOL).In physical and psychological domains, 
significant correlation was observed between disease activity and quality of 
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life. P valus (p=0.001[physical],p=0.01 [psychological]) were significant. This 
suggested that patients with lower quality of life.  had Higher disease activity 
scores. There was no correlation between the age, disease duration and quality 
of life found from the results of the study. 
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AIMS AND OBJECTIVES OF THE STUDY 
a) To study the prevalence of psychosis and other psychiatric disorders in 
patients  with Systemic Lupus Erythematosus 
b) To compare psychiatric morbidity ,stressful life events, quality of life 
between cases and controls. 
c) To correlate the severity of illness with psychosis and other psychiatric 
disorders in patients of systemic lupus erythematosus 
d) To assess the relationship between psychiatric disorders  and quality of 
life in patients with systemic lupus erythematosus 
e) To find the relationship between psychiatric disorders and psychosocial 
stressors in patients with systemic lupus erythematosus 
HYPOTHESIS TO BE TESTED 
1. The prevalence of psychosis and other psychiatric disorders  in patients 
with systemic lupus erythematosus is higher than in controls. 
2. Severity of systemic lupus erythematosus is correlated with psychiatric 
morbidity in patients with systemic lupus erythematosus 
3. Systemic lupus erythematosus patients with psychiatric disorders have 
significant stressful life events than patients without psychiatric 
disorders 
4. Systemic Lupus Erythematosus disease activity is correlated with 
psychosocial stressors. 
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5. Systemic lupus Erythematosus patients with psychiatric disorders  have  
significantly  lower Quality Of Life.(QOL) 
6. Patients with systemic lupus erythematosus has significantly lower 
Quality Of Life (QOL) and more stressful life events than controls. 
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MATERIALS AND METHODS 
INCLUSION CRITERIA FOR CASES 
1. Persons diagnosed as cases of Systemic Lupus Erythematosus by 
Rheumatologists according to American College of Rheumatology 
(ACR)criteria 
2. Age between 18-65yrs of both males and females 
3. Having established disease for 6 months 
4. Ability to give informed consent 
EXCLUSION CRITERIA FOR CASES 
1. History of psychiatric illness prior to onset of Systemic Lupus 
Erythematosus 
2. Comorbid other chronic medical illness 
3. Patients of SLE with end stage systemic disease 
4. Patients with substance dependence except nicotine 
5. Patients with mental retardation/ history of dementia 
6. Not able/Not willing to give  consent 
INCLUSION CRITERIA FOR CONTROLS 
1. Individuals of same age and sex, educational and socioeconomic 
status matched with cases 
2. Individuals with no family history of systemic lupus erythematosus 
3. Individuals with no major medical / psychiatric illness. 
4. Individuals who are willing to give informed consent 
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Exclusion criteria for controls: 
1. Patients with substance dependence except nicotine 
2. Individuals who are not willing to give informed consent 
METHODOLOGY 
 A sample of 30 consecutive patients with an established diagnosis of 
systemic lupus erythematosus, attending the Rheumatology OP as well 
as Inpatients were selected for the study. 
 A sample of 30 controls (Age, sex, marital status, place of living, 
Socioeconomic status matched controls) who attended Govt Rajaji  
Hospital OPD for minor physical ailments were enrolled in this study 
OPERATIONAL DESIGN: 
1. The study was conducted at Government Rajaji Hospital, Madurai, a 
tertiary care centre for 3 months. 
2. The study was approved by Institutional Ethical Committee, 
Government Rajaji Hospital, Madurai. 
3. The study is designed as a case control study. 
4. The sample was chosen from patients attending  Rheumatology OP as 
well as those who were admitted in Rheumatology ward for 
investigation or therapeutic purposes. 
5. Every consecutive patient attending the Rheumatology department were 
selected. 
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6. The cases who met the criteria for Systemic Lupus Erythematosus as per 
American College of Rheumatology (ACR)criteria,have been diagnosed 
by Senior Rheumatologist were chosen and subsequently assessed in 
Psychiatry Department under the supervision of Senior Psychiatrist. 
7. Healthy controls (sociodemographic matched with cases ) were taken 
and assessed for psychiatric disorder 
8. The subjects (cases and controls) were explained about the nature of the 
study and informed consent was obtained. 
9. Socio demographic details and a detailed history were collected from the 
Study population (cases and controls), reliable informants  using a semi-
structured proforma. 
10. Complete physical examination including neurological evaluation and 
detailed mental status examination was done. 
11. All the subjects (cases and controls)were administered Kuppusamy’s 
Socio economic scale 
12. The subjects (cases and controls)  were administered MINI International 
Neuropsychiatric interview and the Hospital Anxiety Depression Scale. 
13. All subjects(cases and controls) were assessed with presumptive 
stressful life event scale, The World Health Organization Quality of Life 
(WHOQOL)-BREF scale 
14. SLE disease activity was measured in cases by using Systemic Lupus 
Activity Measure-Revised (SLAM-R) 
15. Likewise 30 cases and 30 controls were assessed 
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STATISTICAL DESIGN 
Statistical design was formulated using the data collected as above, for 
each of the scales and socio-demographic variables. Statistical analysis was 
done using SPSS (Statistical Package for Social Studies) version 14.0. The 
central values and dispersion were calculated. In comparison of the data for 
categorical variables chi-square and for numerical variables student t test were 
used. For multiple comparisons of more than two numerical variables, ANOVA 
and Scheffe post hoc tests were used. Correlation among variables was studied 
using Pearson’s correlation coefficient. Then all variables were subjected to 
Multiple linear regression, with Quality of Life as the dependent Variable. 
TOOLS USED 
1. Proforma 
2. Kuppusamy rating scale for socioeconomic status 
3. MINI International Neuropsychiatric Interview 
4. Hospital Anxiety and Depression Scale 
5. Presumptive Stressful Life Events Scale 
6. The World Health Organization Quality of Life (WHOQOL- BREF) 
7. Systemic Lupus Activity Measure-Revised (SLAM-R) for measuring 
disease activity 
1. PROFORMA 
Proforma includes personal demographic details, present history, past 
history, Family history, duration of illness, severity of illness, physical and 
mental status examination and Biochemical Investigations. 
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2. KUPPUSAMY SOCIO ECONOMIC STATUS SCALE 
In 1976, this scale was proposed. It was revised in 2012.In the revised 
scale, based on present consumer price index monthly family income was 
modified. This scale is widely    used to measure the socio-economic status of 
an individual based on three variables namely, education, occupation and 
income. 
3. MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW 
The M.I.N.I. is a structured interview for diagnosing the major Axis I 
psychiatric disorders in DSM-IV and ICD-10. The interview is short and takes 
about 15 minutes to administer. It can be administered after a brief training. It 
is a useful instrument in epidemiological studies and trials. It has precise 
questions about psychological problems and the answers are in yes or no 
format. The M.I.N.I. is divided into 16 modules identified by letters, each 
corresponding to a diagnostic category. Validation and Reliability on 
comparing with several structured interviews was found to be good. 
4. HOSPITAL ANXIETY AND DEPRESSION SCALE 
Hospital Anxiety and Depression Scale (HADS), developed to identify 
states of anxiety, depression, and emotional distress, is a self assessment scale 
and applied among patients who are being treated for an array of clinical 
disorders (Zigmond & Snaith et al81) It has a total of 14 items, with responses 
scored on a scale of 0-3, with 3 signifying elevated symptom frequencies. 
Score for each subscale for depression and anxiety ranges from 0 to 21 with 
scores categorized as: 
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Normal (0-7) 
Borderline abnormal (8-10) 
Abnormal (11-21) 
Higher Scores on the whole scale assesses emotional distress with scores 
ranging from 0-42,  
Where higher scores representing distress. It takes on an average 2 to 5 
minutes to complete and is done by the patients themselves. HADS requires the 
person to answer to the questions in relation to how they felt in the past week. 
HADS scale possesses good psychometric properties in requisites of inter 
correlation, homogeneity, factor structure, and internal consistency. 
5. PRESUMPTIVE STRESSFUL LIFE EVENTS SCALE 
It was originally devised by Gurmeet Singh et al in 1983 as a 
modification of the Holmes and Rahes social readjustment rating 
Questionnaire, for use in the Indian population. Due to the simplicity of the 
scale, it can be administered to illiterate population as well. 
The scale items were divided into personal or impersonal, desirable or 
undesirable and ambiguous. It consists of 51 items. It measures the mean 
number of stressful life events in the adult population in their lifetime and in 
the past year. The norms obtained on studying the Indian population indicated 
that an average Indian experiences about ten stressful life events, without 
suffering much physical or psychological distress. They experience an average 
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of two stressful life events in one year. The study also indicated that neurotics 
were likely to report a higher number of life events. They also scored a higher 
stress score for the same event, as compared to the normal subjects. 
6. World Health Organization Quality of Life-BREF(WHOQOL-BREF) 
The WHOQOL-BREF scale 83was developed as a modification of 
WHOQOL-100 scale as it was elaborate and time consuming in large studies. 
The WHOQOL-BREF is brief, convenient to use and gives accurate results. 
The WHOQOL-BREF Field Trial Version assesses the quality of life at domain 
level. Of the 24 facets in WHOQOL-100 scale the most determining items 
were chosen and incorporated in WHOQOL-BREF. 
This scale assess the quality of life in four domains namely, physical, 
psychological, social relationship, and environmental domains. The score of 
each domain is calculated by taking the mean of all items and multiplying by 
factor of four. This is then transformed to a 0-100. Cronbach alpha values for 
each of the four domains demonstrated good internal consistency. It also 
demonstrates good discriminant validity which is comparable to WHOQOL-
100 scale. All four domains of WHOQOL-BREF scale is found to significantly 
contribute to the overall quality of Life and General Health. Among the 
domains the physical health domain is most contributing and social 
relationships domain is least contributing to the overall quality of life. Thus 
WHOQOL-BREF is considered as a good alternative to WHOQOL-100 and a 
rapid means of assessment of quality of life. 
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7. SYSTEMIC LUPUS ACTIVITY MEASURE REVISED (SLAM-R) 
Systemic Lupus Activity Measure-Revised   is used to measure the 
degree of disease activity in patients with systemic lupus erythematosus (SLE) 
within the last month. It was published in 1988 and revised in 1991 (33). 
Content. Specific manifestation in 9 organs/systems, plus 7 laboratory features. 
Number of items. 9 organs/systems, with laboratory category. Response 
options/scale. Organ items scored 0 –3 points if present within the last month 
(severity incorporated into higher score per item). Most items can score a 
maximum of 3 points. Few items can score a maximum of 1 point. The 
laboratory category can score a maximum of 21 points. 
Physician can administer Questionnaire available in paper format 
Maximum score is 81 points. A score of 7 is considered clinically 
important. If the patient scores more than or equal to 7, disease seems to be 
active, if the score is less than seven, the disease is inactive. 
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RESULTS AND INTERPRETATION 
TABLE 1: TABLE SHOWING SOCIODEMOGRAPHIC VARIABLES 
OF THE SAMPLE POPULATION 
S. 
NO 
VARIABLES 
Cases 
(N-30) 
Controls 
(N-30) 
Percentage 
1. Age <20 
21-30 
31-40 
41 and Above 
6 
11 
8 
5 
6 
11 
8 
5 
20.0% 
36.7% 
26.7% 
16.7% 
2. Sex Females 30 30 100% 
3. Marital Status Married 
Unmarried 
22 
8 
22 
8 
73.3% 
26.7% 
4. 
 
Socio 
economic status 
Lower middle 
Upper lower 
3 
27 
3 
27 
10% 
90% 
5. Place of living Rural 
Urban 
17 
13 
17 
13 
56.67% 
43.33% 
 
Table 1 shows the socio demographic profile of the sample population. 
From the table, it is inferred that 20% of population falls below the age 
of 20 years.36.7% of population belongs to the age group of 21-30 years. In the 
age group of 31-40 and above 40, the distribution is 26.7% and 16.7% 
respectively. All the cases are females. 73.3% are married.90% of population 
belongs to upper lower socioeconomic group. Similar distribution was found 
for controls. 
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CHART 1: CHART SHOWING AGE DISTRIBUTION OF THE 
SAMPLE POPULATION (Cases and controls) 
 
CHART 2: SHOWING SEX OF THE SAMPLE POPULATION (cases 
and controls) 
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CHART 3: SHOWING MARITAL STATUS OF THE SAMPLE 
POPULATION (Cases and Controls) 
 
CHART 4: SHOWING SOCIOECONOMIC STATUS OF THE 
SAMPLE POPULATION 
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CHART 5: SHOWING PLACE OF LIVING OF THE SAMPLE 
POPULATION (cases and controls) 
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TABLE 2 : TABLE SHOWING FREQUENCY OF ILLNESS ACTIVITY 
S.NO VARIABLE 
CASES 
(N=30) 
PERCENTAGE 
1. 
SLE Disease 
activity 
Active 
Inactive 
14 
16 
46.70% 
53.30% 
 
From above table, it is found that SLE disease activity is present in 14 
(46.70%) SLE patients. Disease activity is absent in 16(53.30%) patients with 
SLE. 
CHART 6: SHOWING SLE DISEASE ACTIVITY  OF THE SAMPLE 
POPULATION 
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TABLE 3:  TABLE SHOWING THE PREVALENCE OF 
PSYCHIATRIC DISORDERS AMONG CASES OF SLE 
 
Psychiatric disorders No of cases (N=30) Percentage 
Present 
Absent 
17 
13 
56.7% 
43.3% 
 
The above table shows the distribution of psychiatric comorbidity 
among patients with systemic lupus erythematosus. From the table, it is 
inferred that, among the sample of 30 patients, 17 patients (56.7%) have 
psychiatric disorders. 
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TABLE 4:  TABLE SHOWING THE TYPE OF PSYCHIATRIC 
DISORDERS AMONG PATIENTS WITH SLE 
 
Type of Psychiatric 
disorder 
No of  cases (N=30) Percentage 
Major depression 
Dysthymia 
GAD 
Psychosis 
Social anxiety Disorder 
7 
3 
3 
2 
2 
23.3% 
10.0% 
10.0% 
6.7% 
6.7% 
 
The above shows the frequency distribution of the type of psychiatric 
illness among patients with systemic lupus erythematosus. From the table, we 
infer that, among the 17patients with psychiatric comorbidity, 7 patients suffer 
from Major depression, contributing to 23.3% second common, being 
dysthymia and Generalized Anxiety Disorder with a frequency of 3patients 
(10.0%), psychotic disorder and social Anxiety Disorder (9.6%) and in 6.7% of 
patients. 
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TABLE 5:  TABLE SHOWING THE PREVALENCE OF 
PSYCHIATRIC DISORDERS AMONG CONTROLS 
Psychiatric disorders No of controls (N=30) Percentage 
Present 
Absent 
3 
27 
10.00% 
90.00% 
 
The above table shows the distribution of psychiatric comorbidity 
among controls. From the table, it is inferred that, among the sample of 30 
patients, 3 patients (10.0%) have psychiatric disorders. 
TABLE 6: TABLE SHOWING THE TYPE OF PSYCHIATRIC 
DISORDERS AMONG CONTROLS 
Type of Psychiatric 
disorder 
No of cases (N=30) Percentage 
Major depression 
Dysthymia 
GAD 
1 
1 
1 
3.3% 
3.3% 
3.3% 
 
The above shows the frequency distribution of the type of psychiatric 
illness among controls. From the table, we infer that, among 3 patients with 
psychiatric disorders, one (3.3%) suffer from depression, one (3.3%)suffer 
from dysthymia and one(3.3%) suffer from Generalized Anxiety Disorder 
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CHART 7: SHOWING PSYCHIATRIC DISORDERS IN CASES OF SLE 
 
CHART 8: SHOWING TYPE OF PSYCHIATRIC DISORDERS IN 
CASES OF SLE 
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CHART 9: SHOWING PSYCHIATRIC DISORDERS IN CONTROL 
 
CHART 10: TYPE OF PSYCHIATRIC DISORDERS IN CONTROLS 
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TABLE 7:  TABLE SHOWING FREQUENCY DISTRIBUTION OF 
HADS-A (Cases and Controls) 
S. 
NO 
Study 
population 
VARIABLES 
No of 
cases 
PERCENTAGE 
1. Cases 
(N=30) 
 
HADS-A Normal 16 53.30% 
Borderline 9 30.00% 
Abnormal 5 16.70% 
2. Controls 
(N=30) 
HADS-A Normal 28 93.3% 
Borderline 1 3.3% 
Abnormal 1 3.3% 
 
The above table frequency distribution of HADS-A in cases and 
controls. Among cases, 16(53.30%) cases scored as normal, 9(30.00%) scored 
as borderline and 5 cases(16.70%) are abnormal. Among controls, 28 cases 
scored as normal.one scored as borderline and one scored as abnormal 
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TABLE 8:  TABLE SHOWING FREQUENCY DISTRIBUTION OF 
HADS-D (Cases and Controls) 
S. 
NO 
Study 
population 
VARIABLES 
No of 
cases 
PERCENTAGE 
1. Cases 
(N=30) 
 
 
HADS-D Normal 14 46.70% 
Borderline 6 20.00% 
Abnormal 10 33.30% 
2. Controls 
(N=30) 
HADS-D Normal 27 90.00% 
Borderline 1 3.30% 
Abnormal 2 6.70% 
 
The above table frequency distribution of HADS-Din cases and controls. 
Among cases ,14(46.70%) cases scored as normal,6 (20.00%) scored as 
borderline and 5 cases(33.33%) are abnormal. Among controls, 27 cases scored 
as normal.one scored as borderline and 2 scored as abnormal. 
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CHART 11 SHOWING FREQUENCY DISTRIBUTION OF HADS-A  
(CASES AND CONTROLS) 
 
CHART 12: SHOWING FREQUENCY DISTRIBUTION OF HADS-D 
(CASES AND CONTROLS) 
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TABLE  9:  TABLE COMPARING HADS SCORE AND PSLES 
AMONG CASES AND CONTROLS 
S.NO VARIABLE MEAN SD t VALUE 
1. HADS -A CASES 7.27 4.941  
3.738** CONTROLS 3.47 2.569 
2. HADS-D CASES 8.73 5.866  
3.952** CONTROLS 3.93 3.140 
3. PSLE 
EVENTS 
CASES 3.37 1.098  
7.483** CONTROLS 1.57 0.728 
4. PSLE SCORE CASES 184.70 69.305  
7.189** CONTROLS 81.20 37.608 
* =P<0.05, ** = P<0.01 
The above table shows the comparison of PSLE events, scores and 
HADS  scores in patients with systemic lupus Erythematosus and controls. 
From the above table, it is inferred that there is significant difference 
between the two groups in terms of both PSLE events and PSLE score at a p 
value of <0.01. patients with SLE  experienced more number of stressful life 
events and consequently a higher score on the PSLE scale than controls.  
From the above table, it is inferred that there is significant difference 
between two groups in terms of anxiety and depression score in HADS score at 
a p value of <0.01.Patients with systemic lupus Erythematosus experienced 
more anxiety and depression than controls. 
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TABLE 10: TABLE COMPARING QUALITY OF LIFE AMONG 
CASES AND CONTROLS 
S. 
NO 
VARIABLE MEAN 
SD 
VALUE 
t Value 
1. Physical domain Cases 46.90 10.927  
-7.49** Controls 64.40 6.641 
2. Psychological 
domain 
Cases 45.53 9.937  
-9.96** Controls 72.20 10.781 
3. Social Relationship 
domain 
Cases 38.40 17.359  
-10.19** Controls 82.10 15.651 
4. Environmental 
domain 
Cases 41.40 14.402  
-11.36** Controls 82.53 13.629 
5. Total QOL Cases 43.06 11.966  
-11.05** Controls 75.31 10.603 
* =P<0.05, ** = P<0.01 
The above table compares the various domains of the WHO Quality Of 
Life BREF scale among patients with systemic lupus erythematosus and 
healthy controls. From the table, it is inferred that there is a significant 
difference between the two groups in all four domains, namely Physical 
domain, Psychological domain, Social Relationship domain, 
Environmental domain and also the Total Score. From the table, we see 
that patients systemic lupus erythematosus  score less than healthy controls in 
all the domains of the Quality Of Life Scale, which means that the Quality of 
Life is Poorer among patients with sysyemic lupus erythematosus than 
controls. 
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TABLE 11:  TABLE COMPARING AGE OF CASES WITH HADS 
SCORE AND PSLES 
S.NO VARIABLE MEAN SD F Value 
1. HADS-A <20 YEARS 9.17 7.083  
0.776 21-30 YEARS 6.73 4.474 
31-40 YEARS 5.63 5.236 
>41 YEARS 8.80 1.304 
2. HADS-D <20  YEARS 6.83 4.916  
2.794 21-30 YEARS 8.09 5.375 
31-40 YEARS 7.13 6.600 
>41 YEARS 15.00 3.162 
3. PSLES-E <20 YEARS 3.83 1.169  
1.025 
 
 
21-30 YEARS 3.18 1.168 
31-40 YEARS 3.00 1.195 
>41 YEARS 3.80 0.447 
4. PSLES-S < 20 YEARS 203.83 84.241  
0.859 21-30 YEARS 172.91 70.940 
31-40 YEARS 165.25 73.893 
>41 YEARS 218.80 25.975 
 
The above table shows the comparison of Hospital Anxiety Depression 
Scale scores, Presumptive Stressful Life events (PSLE) and PSLE scores 
among the age groups. The sample was divided into 4 groups based on the 
mean age of the sample population. The first group belonging to < 20 years, the 
second group belonging to the age between 21 to 30years, third group 
belonging to the age between 31-40 years and fourth group 41 years. On 
studying the differences in the scores of HADS, PSLE events and PSLE score, 
using One way ANOVA, it is found that, there is no significant difference with 
respect to age and variables between the groups. 
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TABLE 12:  TABLE COMPARING AGE OF CASES WITH QUALITY 
OF LIFE 
S.NO VARIABLE MEAN SD 
Statistical 
Value 
1. Physical domain <20 YEARS 41.000 3.28634  
4.798 21-30 YRS 49.5455 10.2797 
31-40 YRS 54.1250 11.4821 
>41 YEARS 36.6000 6.9857 
2. Psychological 
domain 
<20 YEARS 43.8333 7.9099 1.189 
21-30 YRS 47.9091 9.2353 
31-40 YRS 47.7500 12.4068 
>41 YEARS 38.8000 8.2885 
3. Social Relationship 
domain 
<20 YEARS 38.5000 22.0884 0.795 
21-30 YRS 41.0000 13.8636 
31-40 YRS 41.5000 21.6465 
>41 YEARS 27.6000 9.5289 
4. Environmental 
domain 
<20 YEARS 38.6667 11.4833  
 
2.095 
21-30 YRS 45.7273 14.3533 
31-40 YRS 45.3750 16.5610 
>41 YEARS 28.8000 7.1554 
5. Total QOL <20 YEARS 40.5000 10.7656  
 
2.020 
21-30YRS 46.0455 10.7586 
31-40YRS 47.1875 14.1747 
>41YEARS 32.9500 7.4841 
 
The above table shows the comparison of the Quality Of Life of the 
patients among the age groups. Four dimensions of the QOL scale, Physical 
Domain, Psychological Domain, Social Relationship domain and 
Environmental Domain are compared. The total QOL score is then compared 
between the groups. On analysing the data using Oneway ANOVA, it is found 
that there is no significant difference with respect to qol in between various age 
groups. 
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TABLE 13:  TABLE COMPARING PSLE AND HADS SCORES 
AMONG PATIENTS WITH AND WITHOUT 
PSYCHIATRIC DISORDERS 
S.NO VARIABLE 
PSYCHIATRIC 
DISORDERS 
MEAN SD 
STATISTICAL 
‘t’ VALUE 
1. PSLE 
EVENTS 
PRESENT 4.00 0.791 −4.787** 
df=28 ABSENT 2.54 0.877 
2. PSLE 
SCORE 
PRESENT 227.18 48.290 −5.378 ∗∗ 
df=28 ABSENT 129.15 50.992 
3. HADS-A 
 
PRESENT 10.47 4.230 −6.079** 
df=28 ABSENT 3.08 1.256 
4. 
 
HADS-D 
 
PRESENT 12.88 4.343 −7.657** 
df=28 ABSENT 3.31 1.316 
* =P<0.05, ** = P<0.01 
The above table shows the comparison of PSLE events and PSLE scores 
and comparison of HADS score among patients with and without Psychiatric 
comorbidity. 
From the above table, it is inferred that there is significant difference 
between the two groups in terms of both PSLE events and PSLE score at a P 
value of <0.01. 
From the above table, it is inferred that there is significant difference 
between two groups in terms of anxiety and depression score in HADS score at 
a p value of <0.01. 
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TABLE 14:  TABLE COMPARING PSLE EVENTS AND PSLE 
SCORES AMONG THE TYPES OF PSYCHIATRIC 
COMORBIDITIES 
S. 
NO 
PSLE 
PSYCHIATRIC 
MORBIDITY 
N MEAN SD 
‘F’ 
Value 
POST 
HOC 
TEST 
1. PSLE 
number 
1.No illness 
2.Major depression 
3.Dysthymia 
4.GAD 
5.Psychotic disorder 
6.Social Anxiety 
13 
7 
3 
3 
2 
2 
2.54 
4.29 
3.67 
4.00 
4.00 
3.50 
0.877 
0.951 
0.577 
1.000 
0.0 
0.707 
 
 
4.615** 
 
 
1 vs 2** 
2. PSLE 
score 
1.No illness 
2.Major depression 
3.Dysthymia 
4.GAD 
5.Psychotic disorder 
6.Social Anxiety 
13 
7 
3 
3 
2 
2 
129.15 
255.43 
202.00 
214.33 
222.50 
190.00 
50.992 
57.979 
19.975 
50.935 
16.263 
9.899 
 
 
6.784** 
 
 
1 vs 2** 
* =P<0.05, ** = P<0.01 
The above table compares the Presumptive Stressful life events number 
and score among SLE patients with different types of psychiatric illness. From 
the table, it is inferred that there was a significant difference with respect to 
PSLE events and PSLE scores within the groups, on applying Oneway 
ANOVA. On Post hoc tests, it is found that the difference is significant 
between the patients with no psychiatric morbidity and those with depression. 
Significant difference was not found between patients with no psychiatric 
morbidity and other types of psychiatric illnesses. 
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TABLE 15:  TABLE COMPARING QUALITY OF LIFE AMONG SLE 
PATIENTS WITH AND WITHOUT PSYCHIATRIC 
DISORDERS 
S.NO 
QUALITY OF 
LIFE 
PSYCHIATRIC 
MORBIDITY 
N MEAN SD 
STATISTICAL  
‘t’ VALUE 
1. Physical domain PRESENT 17 39.29 5.665 
7.298** 
ABSENT 13 56.85 7.526 
2. Psychological 
domain 
PRESENT 17 40.59 6.755 
3.756** 
ABSENT 13 52.00 9.891 
3. Social Relationship 
domain 
PRESENT 17 28.77 12.740 
4.473** 
ABSENT 13 51.00 14.433 
4. Environmental 
domain 
PRESENT 17 31.41 7.159 
7.222** 
ABSENT 13 54.46 10.332 
5. Total QOL PRESENT 17 35.01 6.974 
6.636** 
ABSENT 13 53.58 8.346 
* =P<0.05, ** = P<0.01 
The above table compares the various domains of the WHO Quality Of 
Life BREF scale among SLE patients with and without Psychiatric morbidity. 
From the table, it is inferred that there is a significant difference between the 
two groups in all four domains, namely Physical domain, Psychological 
domain, Social Relationship domain, Environmental domain and also the Total 
Score. From the table, we see that patients who have psychiatric comorbidity 
score less than those without psychiatric comorbidity in all the domains of the 
Quality Of Life Scale, which means that the Quality of Life is Poorer among 
those patients who have a comorbid primary psychiatric illness. 
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TABLE 16:  TABLE COMPARING QOL VS PSYCHIATRIC ILLNESSES 
S. 
No 
VARIABLE N MEAN SD 
F 
Value 
POST 
HOC 
TEST 
1. Physical 
domain 
1.No illness 
2.Major depression 
3.Dysthymia 
4.GAD 
5.Psychotic disorder 
6.Social Anxiety 
13 
7 
3 
3 
2 
2 
56.85 
41.43 
42.00 
40.00 
31.50 
34.50 
7.52 
4.72 
3.46 
3.46 
9.19 
4.94 
 
 
12.328 
1vs 2** 
1vs 3* 
1vs 4* 
1vs 5** 
1vs 6** 
2. Psychological 
domain 
1.No illness 
2.Major depression 
3.Dysthymia 
4.GAD 
5.Psychotic disorder 
6.Social Anxiety 
13 
7 
3 
3 
2 
2 
52.00 
39.43 
46.00 
46.00 
34.50 
34.50 
9.89 
6.16 
3.46 
6.92 
4.94 
4.94 
 
 
3.951 
 
 
 
3. Social 
Relationship 
domain 
1.No illness 
2.Major depression 
3.Dysthymia 
4.GAD 
5.Psychotic disorder 
6.Social Anxiety 
13 
7 
3 
3 
2 
2 
51.00 
30.43 
31.33 
39.67 
22.00 
9.50 
14.43 
9.89 
10.97 
13.05 
4.24 
13.43 
 
 
6.046 
 
 
1 vs 6* 
4. Environmental 
domain 
1.No illness 
2.Major depression 
3.Dysthymia 
4.GAD 
5.Psychotic disorder 
6.Social Anxiety 
13 
7 
3 
3 
2 
2 
54.46 
32.29 
35.67 
35.67 
22.00 
25.00 
10.33 
5.88 
4.04 
9.71 
4.24 
0.00 
 
 
11.909 
 
 
1vs 2** 
1vs 5** 
1vs 6** 
5. Total QOL 1.No illness 
2.Major depression 
3.Dysthymia 
4.GAD 
5.Psychotic disorder 
6.Social Anxiety 
13 
7 
3 
3 
2 
2 
53.58 
35.89 
38.75 
40.33 
27.50 
25.87 
8.34 
5.13 
4.83 
7.69 
5.65 
3.36 
 
 
11.783 
 
1vs 2** 
1vs 5** 
1vs 6** 
* =P<0.05, ** = P<0.01 
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The above table compares the Quality of Life among patients with 
various types of Psychiatric comorbidities. The Mean and Standard Deviation 
were calculated for the four domains of the WHO QOL BREF namely Physical 
domain, Psychological domain, Social Relationship domain, Environmental 
domain and for the Total QOL score. 
On applying Oneway ANOVA to the data, there is significant difference 
between the groups pertaining to morbidity on all domains as well as the total 
QOL score. On Post hoc tests, significant difference was found between the 
patients without psychiatric morbidity and those with depression, dysthymia, 
GAD, psychotic disorder Social Anxiety, on Physical domain. No significant 
difference was found between patients with psychiatric disorders and patients 
without psychiatric disorders in psychological domain. Significant difference 
was found between patients without psychiatric disorders and social anxiety 
disorder in social relationship domain. Significant difference was found 
between patients without psychiatric disorders and depression, psychotic 
disorder and social anxiety disorder in environmental domain and Total QOL 
score. 
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TABLE 17 : TABLE COMPARING SLE DISEASE ACTIVITY SCORES 
AMONG SLE PATIENTS WITH AND WITHOUT 
PSYCHIATRIC MORBIDITY 
S. 
NO 
VARIABLE 
PSYCHIATRIC 
MORBIDITY 
N MEAN SD 
STATISTICAL 
‘t’ value 
1. 
SLE DISEASE 
ACTIVITY SCORE 
PRESENT 
ABSENT 
17 
13 
11.88 
4.85 
4.240 
1.573 
−5.672** 
df=28 
* =P<0.05, ** = P<0.01 
From the above table, it is inferred that patients with psychiatric 
disorders had more disease activity score than patients without psychiatric 
disorders significant difference was found between two groups 
TABLE 18: TABLE COMPARING SLE ACTIVITY SCORES AMONG 
THE TYPES OF PSYCHIATRIC COMORBIDITIES 
S. 
NO 
VARIABLE 
PSYCHIATRIC 
MORBIDITY 
N MEAN SD 
‘F’ 
Value 
POST 
HOC 
TEST 
1. SLE disease 
activity score 
 
 
1.No illness 
2.Major depression 
3.Dysthymia 
4.GAD 
5.Psychotic disorder 
6.Social Anxiety 
13 
7 
3 
3 
2 
2 
4.85 
13.85 
10.00 
8.00 
16.50 
9.00 
1.57 
3.34 
4.00 
3.46 
2.12 
4.24 
 
 
13.906 
 
1 vs 2** 
1 vs 5** 
* =P<0.05, ** = P<0.01 
From the above table, it is inferred that among psychiatric disorders, 
significant difference was found between patients without psychiatric disorders 
and major depression and psychotic disorder. 
71 
 
TABLE 19:  TABLE COMPARING PSLE AND HADS SCORES 
AMONG PATIENTS WITH AND WITHOUT SLE 
DISEASE ACTIVITY 
S.NO VARIABLE 
DISEASE 
ACTIVITY 
MEAN N SD 
STATISTICAL 
‘t’ VALUE 
1. PSLE 
EVENTS 
PRESENT 4.07 14 0.829 −4.080** 
df=28 ABSENT 2.75 16 0.931 
2. PSLE 
SCORE 
PRESENT 235.29 14 47.975 −5.107** 
df=28 ABSENT 140.44 16 53.042 
3. HADS-A PRESENT 9.64 14 3.338 −2.723* 
df=28 ABSENT 5.19 16 5.231 
4. HADS-D PRESENT 13.14 14 4.538 −5.415** 
df=28 ABSENT 4.88 16 3.828 
* =P<0.05, ** = P<0.01 
The above table shows the comparison of PSLE events and PSLE scores 
and HADS score  among patients with disease activity and without disease 
activity From the above table, it is inferred that there is significant difference 
between the two groups in terms of both PSLE events and PSLE score at a P 
value of <0.01. 
From the above table, it is inferred that there is significant difference 
between two groups in terms of anxiety and depression score in HADS score at 
a p value of <0.01. 
  
72 
 
TABLE 20: TABLE COMPARING QUALITY OF LIFE OF PATIENTS 
WITH SLE DISEASE ACTIVITY 
S. 
NO 
QUALITY OF 
LIFE 
SLE 
DISEASE 
ACTIVITY 
N MEAN SD 
STATISTICAL  
‘t’ VALUE 
1. Physical domain PRESENT 14 39.14 6.125 4.846** 
df=28 ABSENT 16 53.69 9.645 
2. Psychological 
domain 
PRESENT 14 40.36 6.428 3.019** 
df=28 ABSENT 16 50.06 10.401 
3. Social Relationship  
domain 
PRESENT 14 29.57 9.982 2.926** 
df=28 ABSENT 16 46.12 18.969 
4. Environmental 
domain 
PRESENT 14 30.50 6.595 5.491** 
df=28 ABSENT 16 50.94 12.466 
5. Total QOL PRESENT 14 34.89 6.372 4.517** 
df=28 ABSENT 16 50.20 11.177 
* =P<0.05, ** = P<0.01 
The above table compares the various domains of the WHO Quality Of 
Life BREF scale among SLE patients with and without disease activity. From 
the table, it is inferred that there is a significant difference between the two 
groups in all four domains, namely Physical domain, Psychological domain, 
Social Relationship domain, Environmental domain and also the Total Score. 
From the table, we see that patients with SLE disease activity score less than 
those without disease activity in all the domains of the Quality Of Life Scale, 
which means that the Quality of Life is Poorer among those patients with SLE 
disease activity.  
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TABLE 21:  CORRELATION MATRIX FOR CASES 
 V1 V2 V3 V4 V5 V6 V7 V8 V9 V10 
V1 1          
V2 .51** 1         
V3 .48** .58** 1        
V4 .46* .64** .95** 1       
V5 .30 .59** .61** .67** 1      
V6 -.65** -.56** -.64** -.66** -.69** 1     
V7 -.46* -.46** -.68** -.69** -.50** .64** 1    
V8 -.52** -.53** -.52** -.53** -.43** .58** .87** 1   
V9 -.61** -.58** -.72** -.75** -.69** .77** .88** .81** 1  
V10 -.62** -.59** -.69** -.71** -.63** .80** .93** .92** .95** 1 
* =P<0.05, ** = P<0.01 
V1  –  HADS – A   V2  –  HADS-D 
V3 – PSLE EVENTS  V4  – PSLE SCORE 
V5 – SLE ACTIVITY SCORE V6 – QOL 1 
V7 – QOL 2   V8 – QOL 3 
V9  – QOL 4   V10 – Total QOL 
The Above correlation matrix table, has shown correlation between 
variables including HADS (HADS-A, HADS-D), PSLES (Scores and Events), 
SLE disease activity and Quality of life (all 4 domains and Total).It is inferred 
that there was significant correlation present between all variables (had 
significant p value <0.01) except SLE disease activity score and Anxiety 
component of HADS (HADS-A).There was no significant correlation present 
between disease activity score and HADS-A.(P value-0.30). 
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TABLE 21: MULTIPLE LINEAR REGRESSION WITH QOL AS 
DEPENDENT VARIABLE 
S. 
NO 
INDEPENDENT 
VARIABLE 
R R2 
R2 
Change 
B Beta 
‘t’ for 
B 
SIG ‘t’ 
1. PSLES SCORE 0.72 0.51 0.514 -0.09 -0.55 4.098 p<0.05 
2. HADS-A 0.79 0.62 0.107 -0.89 -0.37 2.765 p<0.05 
 
The above table is based on Multiple linear Regression analysis applied 
to the data collected, keeping Quality Of Life as the Dependent Variable. On 
analysing the data, among all other independent variables, the score of PSLES 
Scores and HADS-A contribute to Quality of Life, significantly, to the level of 
62 %. (Cumulative R = 0.62). The R2 change value of PSLES Score was 0.514 
and that of HADS-A was 0.107, which means HADS-D score contributes to 
51.4% and HADS-A score to 10.7% of the variance, on WHO QOL BREF. 
This value was significant at a P value of < 0.05, which is significant. 
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DISCUSSION 
This study was done to assess the prevalence of psychosis and other 
psychiatric disorders in patients with Systemic Lupus Erythematosus. It also 
aimed to correlate the disease activity with psychiatric disorders in patients 
with Systemic Lupus Erythematosus. In addition to prevalence of psychiatric 
disorders, levels of anxiety and depression, stressful life events and quality of 
life of patients with systemic lupus erythematosus compared with healthy 
controls. 
In present study, 30 cases and 30 healthy controls were enrolled.30 
patients were taken and assessed using MINI, HADS, PSLES and WHOQOL-
BREF.SLE Disease activity was measured using SLAM (Systemic Lupus 
Activity Measure).Thirty (30) healthy controls were matched with socio 
demographic details (Age, sex, place of living, marital status and socio 
economic status).Healthy controls were assessed using MINI, HADS, PSLES 
and WHOQOL-BREF. 
Among cases in the sample, most of the patients were found to be in the 
age group of 21-30 years. Systemic Lupus Erythematosus (SLE) is common in 
the age group of 15-64 years. In present study 36.7 % of population belong to 
the age group of 21-30 years. 
In present study, incidently all thirty (30) patients were females. Age 
distribution was 100%. 
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Systemic lupus erythematosus is more common in females. 
Chandrasekaran et al65 in their study of neuropsychiatric Systemic lupus 
erythematosus in 1992 among Indian patients, reported a female male ratio of 
14:1.In a study of the European Working Party on Systemic Lupus 
Erythematosus on a cohort of 1000 patients in 2003, Systemic lupus 
erythematosus  is up to 10 times more common in women than men and 
typically has a predilection for women in their child-bearing years. 
In present study, sample 56.7% of patients were from rural population 
and 43.3% of patients were from urban population.73.3% of population were 
married. Majority of the population (90%) belonged to upper lower Socio 
Economic Status. 
Systemic Lupus Erythematosus and Psychiatric Disorders 
In present study, among 30 cases of systemic lupus erythematosus we 
found that 17 cases amounting to proportion of 56.7% have psychiatric 
disorders. 
Buchbinder R et al9  and Johnson RT et al17 showed the prevalence of 
psychiatric symptoms ranges from 17% to 75%.Jonson A et al study of 
outcome of Systemic lupus erythematosus found that 38% of patients 
developed neuropsychiatric SLE. Another study by Hugo et al10 in 1996 found 
that point prevalence of psychiatric disorders was 18.2%. K.N.Purandare et al24 
investigated psychiatric morbidity in patients with Systemic lupus 
erythematosus, Hospital based Indian study reported 50% prevalence of 
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psychiatric disorders. The finding of present study is more or less similar to 
studies done by Buchbinder R9 and Johnson RT17 and K.N.Purandare24. 
In controls, 3 persons came out with psychiatric diagnosis. It is 10% of 
sample population which is low compared to 56.7% of sample population with 
systemic lupus Erythematosus. This shows that patients with Systemic lupus 
erythematosus  have high risk of developing psychiatric disorders. 
Systemic Lupus Erythematosus and Types of Psychiatric Disorders 
In our study, most common psychiatric diagnosis was major depressive 
episode. Dysthymia and Generalied Anxiety Disorders were next common. 
Only 2 cases were diagnosed to have psychosis and social anxiety disorder was 
found in 2 patients. Among psychiatric disorders, it is found that 7 cases out of 
17(41.8%),have major depressive episode. Brey RL21, Mok CC22 and Ainidla23  
studies have shown that Depression is commonly reported psychiatric disorder 
in patients  with systemic lupus erythematosus with prevalence rates ranging 
from 16% to 51%.Study done by K.N.Purandare 24reported that depressive 
disorders were common (23.34%)in patients with Systemic Lupus 
Erythematosus. In the study of Stern et al 8 of the 27 non psychotic patients 
were diagnosed to have mild to moderate depression. In the review of Ganz et 
al18,depressive symptoms were twice as common as organic symptoms and 
seve times as common as psychosis. 
Hall et al19 found that patients with systemic lupus erythematosus and 
Rheumatoid arthritis showed the same proportion of organic symptoms(22%) 
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and an equally high proportion of depressive symptoms(51% and 47% 
respectively). Similarly Magner MB -A study 43showed a relatively high 
prevalence  of neurotic depression in patients with Systemic Lupus 
Erythematosus  and Rheumatoid arthritis(40% in SLE and 32% in RA).It has 
shown that depressive disorder is more common than other neuropsychiatric 
disorders in patients with systemic lupus Erythematosus. In the study by Chin 
CN et al 26among malyasians, more than half of the subjects had psychiatric 
disorders and depression was the most frequent diagnosis. 
Present study finding was 23.3% for depressive disorders similar to 
studies of Brey RL21,Mok CC22 and Ainidla23 and K.N.Purandare24. 
The prevalence of psychosis in present study is 6.7%.2 cases of 30 
patients with systemic lupus erythematosus were diagnosed as psychosis. In 
systemic lupus erythematosus, the reported prevalence of psychosis has varied 
from 2% to 7%. 
In the study by Hall et al19 in 1981, 14(25%) of the 56 were classified as 
psychotic. Ganz et al18 in their review in 1972 found only 5 patients (7%) with 
schizophreniform symptoms. Brey et al 21(2002), Scanna et al 
100(2003),London and Hanly et al101 (2007) reported 5 patients(3.9%) of 128 
patients,8(2.48%) of 323 patients,3 of 572 (< 1% ) patients had psychosis 
respectively. 
Stern and Robbins11 found psychosis present in twenty six (26) of fifty 
three (53) Systemic Lupus Erythematosus patients they studied. Prevalence was 
79 
 
about 49%. Symptom presentation and response to treatment were used to 
categorize these patients as having organic brain syndrome, schizophrenia, 
unclassified psychosis, psychotic depression, or steroid-induced psychosis. 
Appenzeller S et al33, evaluated the frequency and risk factors of acute 
psychosis in a large cohort of patients with systemic lupus erythematosus. They 
identified acute psychosis  in 89 of 520 (17.1%).Psychosis primary to CNS 
involvement was diagnosed in 59 of these patients which is about (11.3%). 
Present study finding looks like as same as Ganz et al 18 review and 
prevalence is low while comparing the studies by Hall et al19, Stern and 
Robbins11 and Appenzeller et al33. When compared to many studies, prevalence 
of psychosis is more in present study. 
Brey et al21 (2002) reported 3 of 128 (3%) patients with systemic lupus 
erythematosus had bipolar mood disorder (manic features) and one patient had 
bipolar mood disorder with mixed features. In our study, no single case of 
Bipolar mood disorder was reported. 
It is found that 10% (3 out of 30) of patients were diagnosed to have 
Generalized Anxiety Disorder and 6.7% (2 out of 30) of patients were 
diagnosed as social anxiety disorder in present study. 
In a longitudinal study of active and inactive stages of the disease by 
seguj J et al44 , they reported Generalized anxiety in 5 patients, panic disorders 
in 2 patients and generalized anxiety plus depressive symptoms in one patient. 
In  the study  by Lindal E et al20 of all known systemic lupus erythematosus 
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patients in Iceland, the most common disorder among those with a disorder was 
phobia(56%), followed by Generalized Anxiety (12%),agoraphobia  with and 
without panic, simple, social phobia were found to be more common among the 
Systemic Lupus Erythematosus patients. 
Slattery MJ et al45 study has shown that obsessive compulsive disorder 
was 10 to15 times more common in patients with Systemic lupus 
erythematosus than in community sample. In present study panic disorder and 
obsessive and compulsive disorder were not reported. This may be due to small 
sample size of study population. 
In controls, one (3.3%) presented with Major depressive episode, one 
each (3.3%) presented with dysthymia and Generalized Anxiety Disorder. 
Psychiatric disorders and QOL, PSLES and HADS 
In present study, the sample Population was divided into four age groups 
of less than 20 years, 21 to 30years, 31 to 40 years and a fourth group of above 
41 years. The HADS-A score, HADS-D score and Presumptive Stressful Life 
Events number and score were assessed in all the four groups. The Quality of 
Life was assessed in four domains, namely Physical domain Psychological 
domain, Social Relationship domain and Environmental domain. The total 
score on WHO QOL was then assessed. Mean scores were calculated for all 
four groups. 
On analyzing the data using Oneway ANOVA in our study, no 
difference was found in between the age groups with respect to HADS scores, 
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PSLE scores. In WHOQOL score, significant difference was found in between 
in the age group of 31 to 40with respect to the physical health domain on the 
Quality of Life Scale scores. No significant difference was found in other 
domains or in the total QOL scores. 
We tried to study the Quality of Life of the patients with systemic lupus 
erythematosus, we compared the four domains of the WHO QOL BREF scale 
as well as the total QOL score among patients with and without Psychiatric 
disorders. We found that, in all four domains of the WHO QOL BREF scale, 
there was a significant difference between the patients with and without 
Psychiatric. Patients with Psychiatric disorders scored low on all four domains 
of the Quality of Life Scale. On further analyzing the data using Oneway 
ANOVA, we tried to find between which of the Illnesses, there was a 
significant difference. In physical domain Significant difference was found 
between patients without psychiatric disorders and patients with “Depression, 
Dysthymia, Generalised Anxiety Disorder, psychotic disorder and Social 
Anxiety Disorder”. In psychological domain there was no significant difference 
between patients without psychiatric disorders and patients with any of the 
psychiatric disorder”. In social domain, significant difference was found for 
Social Anxiety Disorder”. In environmental domain, Significant difference was 
found between patients without psychiatric disorders and patients with 
Depression, psychotic disorder and Social Anxiety Disorder”. 
In total QOL, Significant difference was found for Depression, 
psychotic disorder” and Social Anxiety Disorder”. There was no significant 
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difference for dysthymia” and “Generalized Anxiety Disorder. In our study has 
shown that SLE patients with psychiatric disorders scored less in WHOQOL-
BREF Scale compared to patients without psychiatric disorders. It indicates 
that patients with psychiatric morbidity have poorer quality of life. 
On comparing with controls, significant difference was found in all 
domains. This shows that patients with SLE have poorer quality of life than 
controls. 
Studies have found quality of life in SLE was poorer when compared to 
other medical illness.Study47 from multiethnic LUMINA cohort examined 
health related quality of life in patients with systemic lupus erythematosus and 
concluded that in patients with SLE, poor baseline Health Related Quality Of 
Life was highly predictive of subsequent poor Health Related Quality Of Life. 
We tried to assess the stressful life events and compare them between 
patients with systemic lupus erythematosus and healthy controls. When we 
analysed data by using ‘t’ test .significant difference was found between two 
groups. patients with Systemic lupus erythematosus tend to experience more 
number of Stressful Life Events and consequently score high on the 
Presumptive Stressful Life Events Scale. 
In the present study, on assessing the Stressful Life events and 
comparing them between SLE patients with Psychiatric disorders and those 
without Psychiatric disorders, there was a significant difference between the 
two groups. 
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On further analyzing the data using Oneway ANOVA, on comparing the 
scores among the various types of Psychiatric disorders in our study, we found 
a significant difference between patients with No illness and Depression. There 
was no significant difference between the “No illness” and other types of 
Psychiatric disorders. These findings suggest that patients with Systemic lupus 
erythematosus who have comorbid Depression tend to experience more number 
of Stressful Life Events and consequently score high on the Presumptive 
Stressful Life Events Scale. 
In present study, we tried to find the differences in the Hospital Anxiety 
Depression Scale Scores,between cases and controls. The mean scores on 
HADS was calculated. On applying the student t test for the collected data, we 
found that there was significant difference between cases and controls. This 
finding indicates that patients with systemic lupus erythematosus experience 
more anxiety and depressive symptoms when compared to healthy controls. 
We found that there was significant difference in Hospital Anxiety 
Depression Scale Scores, between SLE patients with and without psychiatric 
disorders. On applying t test, we concluded that SLE patients with psychiatric 
disorders scored high in HADS which is indicative of they have more anxiety 
and depression than SLE patients without psychiatric disorders. 
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SLE disease activity with psychiatric disorders, QOL, PSLES, HADS 
In present study, On applying t test there is significant difference 
between disease active and inactive group with respect to psychiatric 
morbidity. On further analyzing the data using Oneway ANOVA, on 
comparing the scores among the various types of Psychiatric comorbidities in 
our study, we found a significant difference between patients without 
Psychiatric illness and patients with Depression and psychotic disorder. There 
was no significant difference between the patients without psychiatric disorders 
and the patients with other types of Psychiatric disorders. Disease activity was 
associated with depressive episode and psychotic disorder. 
Nery FG et al57 examined the hypothesis that Systemic Lupus 
Erythematosus Disease activity is related to the presence of and severity of 
major depression in patients with SLE. Seventy one patients  with SLE were 
evaluated. Patients with major depression presented a trend toward having 
greater severity of SLE disease activity compared with those without major 
depression. These results support the hypothesis that SLE disease activity is a 
potential risk factor for the presence and severity of major depression in 
patients with SLE. The result of this study is similar to present study 
Appenzeller S33 et al found that fifty nine (59) patients of 520 had  
Psychosis.19 patients had psychosis  secondary to SLE at disease onset  and 
was associated with disease activity. 
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Lim Lc et al25 observed a significant correlation between psychiatric 
morbidity and clinical disease activity among patients of SLE.Hugo et al10 
found that psychiatric morbidity was not associated with disease activity. The 
finding of our study is similar to study by Lim Lc et al25. 
On studying the Quality of Life of the patients with Systemic lupus 
Erythematosus, we compared the four domains of the WHO QOL BREF scale 
as well as the total QOL score among patients with and without SLE disease 
activity. We found that, in all four domains of the WHO QOL BREF scale, 
there was a significant difference between the patients with and without SLE 
disease activity. Patients with SLE disease activity scored low on all four 
domains of the Quality of Life Scale. 
A study of the quality of life (QOL) in SLE patients and correlation with 
disease activity was conducted by Khanna S et al50 and found that patients with 
active disease showed significantly lower scores in the physical and 
psychological domains than patients with inactive disease. There was no 
significant difference was found in the domains of social and environmental 
QOL. Study result differs in social and environmental domains from our study. 
As per our study, on assessing the Stressful Life events and comparing 
them between patients with SLE disease activity and without SLE disease 
activity, there was a significant difference between the two groups. The 
findings suggest that patients who experience more number of stressful life 
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events tend to have active disease when compared to patients who experience 
less stressful life events. 
Segui J et al44 compared active and inactive stages of the disease and 
reported when SLE patients were clinically inactive, they showed lower levels 
of psychological distress. 
In present study, we tried to find the differences in the Hospital Anxiety 
Depression Scale Scores between patients with and without SLE disease 
activity. There was a significant difference between the two groups. Patients 
with disease activity scored more in HADS than patients without disease 
activity. The difference was more significant for HADS-D than for HADS-A. 
On correlation matrix of variables among patients with systemic lupus 
Erythematosus, there is significant correlation between almost all variables.But 
there is no significant correlation between HADS-Anxiety score and SLE 
disease activity score. It may be inferred that Anxiety in Systemic lupus 
Erythematosus patients may be due to other factors like stressful life events. 
There is  a strong negative correlation between HADS score and quality 
of life. This indicated that Anxiety and Depression significantly impair the 
quality of life in patients with systemic lupus Erythematosus. This highlights 
the urgent need for hidden psychiatric morbidity in patients with systemic 
lupus Erythematosus. 
There is significant negative correlation between stressful life events and 
quality of life and significant positive correlation between stressful life events 
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and disease activity and psychiatric morbidity. It becomes obvious from these 
findings  that experiencing more stressful life events worsen the disease or 
activate Systemic Lupus Erythematosus and also increases the incidence of 
psychiatric morbidity. It is quiet understandable this may lead on to poor 
quality of life. 
Stressful life events are unpredictable and cannot be prevented. But 
experience of stress or perceived stress can be reduced by specific measures 
like stress management training and other focused psychological therapies. 
Early psychological intervention focusing in these areas would definitely be 
helpful in reducing disease activity, psychiatric morbidity and  improve quality 
of life. 
Finally when analyzing the variables or factors contributing to quality of 
life in patients with systemic lupus Erythematosus, it is found that there are  
two factors significantly contributed to poor quality of life. They are stressful 
life events which contributed to 51.4% and HADS-Anxiety score which 
contributed to 10.7%. 
No other factors found to have significant contribution to the poor 
quality of life in patients with systemic lupus Erythematosus. This highlights 
the need for inclusion of mental health professional in the management of 
patients with systemic lupus Erythematosus even in the absence of psychiatric 
morbidity. 
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LIMITATIONS OF THE STUDY 
1. This study is a case control study, done in a short period. Hence the 
longitudinal course and outcome of the patients could not be assessed. 
2. The study sample is small. Further studies on a larger sample are 
needed. 
3. Since the study has been done in a government Hospital, in which 
majority of the population belongs to middle and lower socioeconomic 
status, these findings cannot be extrapolated to the general population. 
CONCLUSION 
The study findings reveal, with respect to the Hypothesis that 
1. Psychiatric disorders are highly prevalent in patients with Systemic 
Lupus Erythematosus. 
2. Major depressive disorder is the most common Psychiatric disorder 
associated with Systemic Lupus Erythematosus. 
3. The risk of developing Psychiatric illnesses (Depression and psychotic 
disorder) increases with increasing severity of systemic lupus 
erythematosus. 
4. Systemic Lupus Erythematosus Patients with more number of Stressful 
life events are prone to develop Psychiatric disorders. 
5. Patients with Major Depression have experienced more number of 
Stressful Life Events as compared to other disorders, like Generalised 
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Anxiety Disorder, Social Anxiety Disorder or Dysthymia and psychotic 
disorder. 
6. The Quality of life is poorer in patients with active systemic lupus 
Erythematosus. 
7. The Quality of Life in patients with systemic lupus erythematosus is 
poorer with psychiatric disorders than patients without psychiatric 
disorders. 
8. Stressful life events and Anxiety are the major contributors for poorer 
quality of life in patients with Systemic Lupus Erythematous. 
Based on the findings in present study, it is shown that Systemic Lupus 
Erythematosus patients have a high risk of Psychiatric illness and when 
emotional factors are not addressed adequately, the morbidity of these patients 
may increase. Early recognition and treatment of Psychiatric illness by 
involving a Psychiatrist as a team member in the Rheumatology clinic may lead 
to a better outcome. Further studies to characterize the pattern of Psychiatric 
morbidity and their impact on daily living and longitudinal studies to observe 
improvement with pharmacotherapy and psychotherapy are necessary. 
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ANNEXURE - I 
PROFORMA 
NAME:                                                   OP/IP NO: 
AGE:                                                       INFORMANT: 
ADDRESS:                                              PHONE NUMBER: 
EDUCATIONAL STATUS:  Profession/Graduate or post 
graduate/Intermediate or post high school diploma/High school/ Middle 
school/Primary school/Illiterate 
OCCUPATION: Profession/Semi-Profession/Clerical, Shop-owner, 
Farmer/Skilled worker/Semi-skilled worker/Unskilled worker/Unemployed                             
INCOME: 
MARITAL STATUS:              TYPE OF FAMILY: nuclear/joint/extended 
Number of family members: 
PRESENTING COMPLAINTS :( RHEUMATOLOGICAL) 
Duration :                                                                                                                  
Diagnosis  : 
Mode of treatment: 
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PRESENTING COMPLAINTS: (PSYCHIATRIC) 
Duration:                                                               H/O Treatment                                                                                                             
PAST HISTORY:                                                                                                 
Psychiatric illness:                   Suicidal attempt:               Stressors:                                                                                                                                                                                                                                                                                                  
Medical/surgical illness:          others:                                                                                             
FAMILY HISTORY:                                                                                                        
Type of family:                                     H/O psychiatric illness:                                           
No of family members:                         H/O suicidal attempts:                                           
Earning members:                                 H/O missing persons/MR:                                            
Total income: 
PERSONAL HISTORY:                                                                                                  
AN/PN history:                             Developmental milestones:                                                                                                                                                                     
Academic performance:                Occupational history: 
PREMORBID PERSONALITY: 
GENERAL EXAMINATION:                                                                                              
B.P:              mm. Hg      P.R:  /Min                                                                      
Self-Inflicted Wounds:                                                                                                        
C.V.S:                                                                                                                                 
R.S:                                                                                                                             
ABDOMEN:                                                                                                                      
C.N.S: 
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MENTAL STATUS EXAMINATION:                                                                                                                                   
General appearance/co-operation:                                                                                 
Psychomotor activity:                                                                                                       
Talk:                                                                                                                 
Thought:                                                                                                     
Perception:                                                                                                                                    
Mood 
DIAGNOSIS: 
LAB INVESTIGATIONS: 
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ANNEXURE – II 
SCALE 
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ANNEXURE - III 
MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW 
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ANNEXURE - IV 
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ANNEXURE - V 
 
 
 
 
111 
 
 
 
 
 
 
 
 
 
 
 
 
112 
 
ANNEXURE - VI 
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ANNEXURE - VII 
SYSTEMIC LUPUS ACTIVITY MEASURE (SLAM) 
CONSTITUTIONAL 
1. Weight loss Score: _____ 
0: Absent 
 
2: > 10% body weight 
_____ Unknown 
2. Fatigue Score:_____ 
0: Absent 
1: Little or no limit on 
normal activity 
2: Limits normal activity 
_____ Unknown 
3. Fever Score:_____ 
0: Absent 
1: 37.5 – 38.5º C or 99.5 – 
101.3º F 
2: > 38.5º C or > 101.3º F 
_____ Unknown 
 
  
116 
 
INTEGUMENT 
4. Oral/nasal ulcers, periungal Score:_____ 
erythema, malar rash, photosensitive 
rash, or nailfold infarct 
0: Absent 
1: Present 
_____ Unknown 
5. Alopecia Score:_____ 
0: Absent 
1: Hair loss with trauma 
2: Alopecia observed 
_____ Unknown 
6. Erythematous, macular or pa- Score: _____ 
pular rash, discoid lupus, lupus 
profundus, or bullous lesions 
0: Absent 
1: < 20% Total Body Surface 
Area (TBA) 
2: 20 – 50% TBA 
3: > 50% TBA 
_____ Unknown 
7. Vasculitis (leukocytoclastic Score:_____ 
vasculitis, urticaria, palpable 
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purpura, livedo reticularis, 
ulcer or panniculitis) 
0: Absent 
1: < 20% TBA 
2: 20 – 50% TBA 
3: > 50% TBAor necrosis 
_____ Unknown 
EYE 
8. Cytoid bodies Score:_____ 
0: Absent 
1: Present 
2: Visual acuity < 20/200 
_____ Unknown 
9. Hemorrhages (retinal or choroidal) 
or episcleritis Score:_____ 
0: Absent 
1: Present 
3: Visual acuity < 20/200 
_____ Unknown 
10. Papillitis or pseudotumor 
cerebri Score:_____ 
0: Absent 
1: Present 
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3: Visual acuity < 20/200 or 
field cut 
_____ Unknown 
RETICULOENDOTHELIAL 
11. Lymphadenopathy Score:_____ 
0: Absent 
1: Shotty 
2: Diffuse or nodes > 1 cm 
x 1.5 cm 
_____ Unknown 
12. Hepato- or splenomegaly Score:_____ 
0: Absent 
1: Palpable only with 
inspiration 
2: Palpable without 
inspiration 
_____ Unknown 
PULMONARY 
13. Pleurisy / pleural effusion Score:_____ 
0: Absent 
1: Shortness of breath or 
pleuritic chest pain 
2: Shortness of breath or 
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pleuritic chest pain with 
exercise 
3: Shortness of breath or 
pleuritic chest pain at rest 
_____ Unknown 
14. Pneumonitis Score:_____ 
0: Absent 
1: X-ray infiltrates only 
2: Shortness of breath with exercise 
3: Shortness of breath at rest 
_____ Unknown 
CARDIOVASCULAR 
15. Raynaud’s phenomenon Score:_____ 
0: Absent 
1: Present 
_____ Unknown 
16. Hypertension (diastolic 
pressure, mmHg) Score:_____ 
0: < 90 
1: 90 – 104 
2: 105 – 114 
3: > 115 
_____ Unknown 
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17. Pericarditis / carditis Score:_____ 
0: Absent 
2: Positional chest pain or 
arrhythmia 
3: Myocarditis with hemodynamic 
compromise 
and/or arrhythmia 
_____ Unknown 
GASTROINTESTINAL 
18. Abdominal pain (serositis, 
pancreatitis, or Score:_____ 
ischemic bowel, etc) 
0: Absent 
1: Complaint 
2: Limiting pain 
3: Peritoneal signs / ascites 
_____ Unknown 
NEUROMOTOR 
19. Stroke syndrome, includes Score:_____ 
mononeuritis multiplex (MM), 
reversible neurologic deficit 
(RND), cerebrovascular accident 
(CVA), or retinal vascular 
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occlusion (RVO) 
0: Absent 
2: RND, MM, cranial neuropathy 
or chorea 
3: C VA, myelopathy, or RV O 
_____ Unknown 
20. Seizure Score:_____ 
0: Absent 
2: 1 or more per month 
3: Status epilepticus 
_____ Unknown 
21. Cortical dysfunction Score:_____ 
0: Absent 
1: Mild depression, personality 
disorder, or cognitive 
deficit 
2: Change in sensorium, severe 
depression, or limiting 
cognitive impairment 
3: Psychosis, dementia, or 
coma 
_____ Unknown 
22. Headache (including migraine Score:_____ 
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equivalents and aseptic meningitis) 
0: Absent 
1: Symptoms only 
2: Interferes with normal 
activities / aseptic meningitis 
_____ Unknown 
23. Myalgia / Myositis Score:_____ 
0: Absent 
1: Symptoms only 
2: Limits some activity 
3: Incapacitating 
_____ Unknown 
JOINTS 
24. Joint pain Score:_____ 
0: Absent 
1: Arthralgia only 
2: Objective synovitis 
3: Limits function 
_____ Not recorded 
LABORATORY 
25. Hematocrit (mg/dL) Score:_____ 
0: > 35 
1: 30 – 35 
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2: 25 – 29 
3: < 25 
_____ Not recorded 
Assessment of SLE / G.K.W. Lam & M. Petri 
26. White blood cell count 
(per mm3) Score:_____ 
0: > 3500 
1: 2000 – 3500 
2: 1000 – 1999 
3: < 1000 
_____ Not recorded 
27. Lymphocyte count (per mm3) Score:_____ 
0: 1500 – 4000 
1: 1000 – 1499 
2: 500 – 999 
3: < 500 
_____ Not recorded 
28. Platelet count (x 1000 per mm3) Score:_____ 
0: > 150 
1: 100 – 149 
2: 50 – 99 
3: < 50 
_____ Not recorded 
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29. Westergren ESR (mm/hr) Score:_____ 
0: < 25 
1: 25 – 50 
2: 51 – 75 
3: > 75 
_____ Not recorded 
30 Serum creatinine (mg/dL) or Score:_____ 
creatinine clearance (% normal) 
0: 0.5 – 1.3 or 80 – 100% 
1: 1.4 – 2.0 or 60 – 79% 
2: 2.1 – 4.0 or 30 – 59% 
3: > 4.0 or < 30% 
_____ Not recorded 
31. Urine sediment 
(per high power field) Score:_____ 
0: Normal 
1: 6 – 10 RBC or 6 – 10 
WBC; OR 0-3 granular 
or 0-3 non RBC casts; OR 
trace – 1+ protein (<500 
mg/L24 hr urine protein) 
2: 11 – 25 RBC or 11 – 25 
WBC; OR >3 granular or 
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>3 non RBC casts; OR 2 
– 3+ protein (>500 mg – 
3.5 g/L24 hr urine protein) 
3: > 25 RBC or > 25 WBC; 
OR any RBC casts; OR 
4+ protein > 3.5 g/L24 
hr urine protein) 
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KEY TO MASTER CHART 
SEX: 
1- MALE 
2- FEMALE 
PLACE OF LIVING: 
1-RURAL 
2-URBAN 
MARITAL STATUS: 
1- MARRIED 
2- UNMARRIED 
3-WIDOW 
SES – SOCIECONOMIC STATUS 
1- UPPER 
2- UPPER MIDDLE 
3- MIDDLE/LOWER MIDDLE 
4- LOWER/UPPER MIDDLE 
5- LOWER 
PSYCHIATRIC DIAGNOSIS 
1-NIL 
2-MAJOR DEPRESSIVE EPISODE 
3-DYSTHYMIA 
4-GENERALIZED ANXIETY DISORDER 
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5-PSYCHOTIC DISORDER 
6-SOCIAL ANXIETY DISORDER 
7-OTHERS 
HADS – A – HOSPITAL ANXIETY DEPRESSION SCALE – ANXIETY 
SCORE 
HADS – D – HOSPITAL ANXIETY DEPRESSION SCALE – DEPRESSION 
SCORE 
HADS – A INF: HADS – A INFERENCE: 
1-NORMAL 
2-BORDERLINE 
3-ABNORMAL 
HADS – D INF : HADS – D INFERENCE 
1-NORMAL 
2-BORDERLINE 
3-ABNORMAL 
PSLE –E : PRESUMPTIVE STRESSFUL LIFE EVENTS 
PSLE – S :PRESUMPTIVE STRESSFUL LIFE EVENTS SCORE 
SYSTEMIC LUPUS ACTIVITY MEASURE-R 
1-DISEASE INACTIVE 
2-DISEASE ACTIVE 
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MASTER CHART 
SNO AGE SEX U/R MARITAL  SES 
PSY 
DIA 
HADS 
A  
HADS D 
HADS 
A I 
HADS 
D I 
PSLES 
E 
PSLES 
S 
1 19 2 2 1 4 2 8 14 2 3 6 369 
2 24 2 2 1 4 2 9 15 2 3 4 216 
3 27 2 1 1 3 2 11 17 2 3 5 278 
4 25 2 1 1 4 1 4 3 1 1 1 37 
5 33 2 1 1 4 1 2 3 1 1 3 157 
6 19 2 2 2 4 1 4 2 1 1 3 150 
7 48 2 1 3 4 3 10 18 2 3 4 192 
8 30 2 2 1 4 4 15 8 3 2 4 222 
9 36 2 2 1 4 1 3 3 1 1 1 40 
10 28 2 1 2 4 1 2 4 1 1 2 111 
11 52 2 1 1 4 3 7 14 1 3 3 189 
12 30 2 1 1 4 1 3 5 1 1 3 112 
13 19 2 2 1 4 4 17 10 3 2 3 160 
14 40 2 2 1 4 2 11 19 2 3 3 187 
15 20 2 1 2 4 5 3 4 1 1 4 211 
16 19 2 2 2 4 6 19 9 3 2 4 183 
17 25 2 1 2 3 1 5 3 1 1 3 177 
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18 29 2 1 2 3 3 7 16 1 3 4 225 
19 41 2 2 1 4 2 11 17 2 3 4 241 
20 31 2 2 1 4 1 1 1 1 1 3 153 
21 37 2 1 1 4 4 16 10 3 2 5 261 
22 33 2 1 1 4 2 12 15 2 3 4 259 
23 25 2 1 1 4 1 5 6 1 1 4 216 
24 23 2 2 1 4 6 14 8 3 2 3 197 
25 39 2 1 1 4 1 3 4 1 1 3 162 
26 43 2 1 1 4 5 9 10 2 2 4 234 
27 34 2 2 1 4 1 2 3 1 1 2 103 
28 44 2 1 1 4 2 10 16 2 3 4 238 
29 28 2 1 1 4 1 2 4 1 1 2 111 
30 19 2 2 2 4 1 4 2 1 1 3 150 
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QUALITY OF LIFE CYCLE 
 
SNO QOL 
                        
 
1 2 3 4 5 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 
1 3 3 3 2 2 2 3 3 3 4 2 2 2 3 2 2 2 2 3 2 3 3 3 2 2 
2 2 2 2 2 2 2 2 2 3 3 2 2 2 2 2 2 2 2 3 2 3 3 3 2 2 
3 3 3 2 2 2 2 2 2 2 3 3 3 2 2 2 2 2 3 2 2 3 2 3 3 2 
4 4 4 4 3 4 4 4 4 4 4 3 3 4 4 4 4 4 4 4 4 3 3 4 4 4 
5 3 3 3 4 4 3 3 3 4 4 3 3 3 4 4 3 3 4 3 3 3 3 4 3 5 
6 4 3 4 4 3 3 3 3 3 4 3 3 3 3 4 3 3 3 4 3 3 3 3 3 4 
7 2 2 2 2 3 2 2 2 2 3 2 2 3 3 2 2 2 2 3 2 3 3 3 3 1 
8 2 2 2 2 3 2 2 2 2 3 2 2 3 3 2 2 2 2 3 2 3 3 3 3 1 
9 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 
10 4 3 4 4 3 4 3 3 4 4 3 3 4 3 4 4 4 3 3 3 3 4 4 4 4 
11 2 2 2 2 2 3 2 2 2 3 2 3 2 2 2 2 2 2 2 2 2 2 2 2 2 
12 3 3 2 3 2 3 3 3 3 4 3 3 3 3 4 3 3 3 2 2 3 2 3 3 4 
13 3 3 3 2 3 3 2 3 3 3 2 3 3 2 2 2 2 2 3 3 3 3 3 3 2 
14 2 2 2 2 2 3 3 3 2 3 2 2 2 2 3 3 3 3 2 1 2 2 3 3 2 
15 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 
16 3 2 2 2 2 2 2 2 2 1 2 2 2 1 2 2 2 2 1 1 1 1 2 2 1 
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17 3 3 2 2 3 3 3 3 3 3 2 2 2 3 4 3 3 3 3 3 2 2 3 3 4 
18 2 2 2 2 2 3 3 3 3 3 2 3 2 2 3 2 2 2 2 2 2 2 3 2 2 
19 2 2 2 2 2 2 2 2 2 3 2 2 2 2 1 2 2 2 2 2 2 3 2 3 2 
20 3 3 3 3 3 4 3 3 3 4 3 3 3 4 4 3 3 3 4 4 3 3 3 3 4 
21 1 1 1 2 2 2 2 2 2 2 2 2 2 1 1 2 2 2 2 2 2 2 2 2 1 
22 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
23 3 3 3 2 3 2 3 3 2 2 2 3 3 3 3 3 3 2 2 3 3 3 3 3 3 
24 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 1 2 2 1 2 2 2 2 1 
25 3 3 2 2 2 3 2 2 3 3 3 3 3 3 4 3 3 3 2 2 2 2 3 3 4 
26 1 1 2 2 2 1 1 2 2 2 2 2 2 1 1 1 1 2 1 2 2 2 2 1 1 
27 3 3 2 2 3 3 3 3 4 4 3 3 3 4 4 3 3 3 3 3 2 2 3 3 4 
28 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 1 
29 4 3 4 4 3 4 3 3 4 4 3 3 4 3 4 4 4 3 3 3 3 4 4 4 4 
30 4 3 4 4 3 3 3 3 3 4 3 3 3 3 4 3 3 3 4 3 3 3 3 3 4 
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SYSTEMIC LUPUS ACTIVITY MEASURE (SLAM) INDEX 
S. 
No 
1 2 3 4 5 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 total 
IN 
FE 
1 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 1 1 1 1 2 0 0 14 2 
2 1 2 0 0 2 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 2 1 1 1 1 1 2 0 1 18 2 
3 3 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 1 2 1 1 1 1 0 1 0 0 17 2 
4 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 1 0 0 0 1 0 0 7 1 
5 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 1 6 1 
6 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 1 0 0 7 1 
7 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 1 1 1 0 1 0 1 10 2 
8 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 0 1 2 0 0 10 2 
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 3 1 
10 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 4 1 
11 1 1 0 1 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 1 1 1 1 0 3 0 0 14 2 
12 1 1 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 4 1 
13 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 4 1 
14 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 1 1 1 2 0 0 10 2 
15 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 3 1 2 1 1 2 1 1 2 0 1 18 2 
16 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0 0 1 0 0 6 1 
17 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 5 1 
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18 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0 0 0 0 0 6 1 
19 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 1 1 0 0 0 0 9 2 
20 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 3 1 
21 3 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 0 0 0 10 2 
22 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 1 1 1 1 1 1 1 0 1 15 2 
23 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 6 1 
24 1 2 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 1 1 1 0 0 1 12 2 
25 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 4 1 
26 1 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 1 1 1 1 1 1 1 1 0 0 15 2 
27 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 3 1 
28 1 2 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 0 0 14 2 
29 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 4 1 
30 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 
 
0 0 0 1 1 0 0 7 1 
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